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ABSTRACT 
 
 
The central dogma of biology asserts that DNA is transcribed into RNA and RNA is 
translated into protein. However, this overtly simplistic assertion fails to portray the highly 
orchestrated and regulated mechanisms of transcription and translation. During the process of 
transcription, RNA provides the template for translation and protein synthesis as well as the 
structural and sequence specificity of many RNA and protein-based machines. While only 1-5% 
of the genome will escape the nucleus to be translated as mRNAs, complex, parallel, highly- 
conserved mechanisms have evolved to regulate specific mRNAs. Trans-acting factors bind cis-
elements in both the 5‟ and 3‟ untranslated regions of mRNA to regulate their stability, 
localization, and translation. While a few salient examples have been elucidated over the last few 
decades, mRNA translation can be reversibly regulated by the shortening and lengthening of the 
3‟ polyadenylate tail of mRNA. CPEB, an important factor that nucleates a complex of proteins 
to regulate the polyadenylate tail of mRNA, exemplifies a major paradigm of translational 
control during oocyte maturation and early development. CPEB function is also conserved in 
neurons and somatic foreskin fibroblasts where it plays an important role in protein synthesis 
dependent synaptic plasticity and senescence respectively. Focusing on the function of CPEB 
and its role in mRNA polyadenylation during human cellular senescence, the following 
dissertation documents the important finding that CPEB is required for the normal 
polyadenylation of p53 mRNA necessary for its normal translation and onset of senescence. 
Cells that lack CPEB have abnormal levels of mitochondria and ROS production, which are 
demonstrated to arise from the direct result of hypomorphic p53 levels. Finally, in an attempt to 
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recapitulate the model of CPEB complex polyadenylation in human somatic cells, I unexpectedly 
find that Gld-2, a poly(A) polymerase required for CPEB-mediated polyadenylation in Xenopus 
laevis oocytes, is not required for p53 polyadenylation, but instead regulates the stability of a 
microRNA that in turn regulates CPEB mRNA translation. Furthermore, I demonstrate that 
CPEB requires Gld-4 for the normal polyadenylation and translation of p53 mRNA. 
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CHAPTER I 
 
INTRODUCTION 
 
 
The lifecycle of a messenger RNA (mRNA) begins in the nucleus of all eukaryotic cells 
where newly synthesized RNAs are rapidly transcribed from a deoxyribonucleic acid (DNA) 
template. The nascent RNA will co-transcriptionally receive a methylated-guanosine cap to 
protect the 5‟ end and will shed intronic sequences during the process of RNA splicing, 
culminating with a 3‟ cleavage and addition of a polyadenylate (poly(A)) tail (Danckwardt et al. 
2008).  Even before the process of transcription has terminated, the nascent RNA is refashioned 
by precipitant small nuclear ribonucleic protein machines (snRNPs), heterogeneous nuclear 
ribonucleic proteins (hnRNPs) and serine/arginine (SR) proteins (Dreyfuss et al. 2002). This 
highly orchestrated birthing of the mRNA is just the beginning as proteins continue to be 
deposited along its entire ribonucleic sequence, some of which will stay stably bound for the 
remainder of the journey, while other proteinacious factors will come and go (Dreyfuss et al. 
2002; Moore 2005).  Remarkably, only 10% of all transcribed RNA will leave the nucleus and 
only as little as 1-5% will leave as mRNA (Mattick and Makunin 2005). This transcriptional 
intermediate has transformed from a simple stretch of ribonucleic acids into a highly modified 
and now seemingly mature amalgamation of both proteins and mature messenger RNA known as 
the mRNA-protein complex (mRNP). Importantly, the RNA-binding proteins associated with the 
mRNP will dictate the fate of the mRNA. 
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 The mRNP is now ready for export from the nucleus to the cytoplasm in procession 5‟ to 
3‟, where it will be translated into protein by the ribosome, a complex >3 mega-dalton machine 
of  roughly 60% RNA and  40% protein (Kohler and Hurt 2007). mRNA translation, a vastly 
complex process involving many factors whereby the mRNA is decoded by the ribosome from 
trinucleotide sequences called condons can simply be divided into three steps; initation, 
elongation and termination (Sonenberg and Hinnebusch 2009; Jackson et al. 2010). Translation 
initiation constitutes the assembly of the elongation-competent 80S ribosome on the mRNA, 
where the initiator methionine anti-codon is base-paired with the start AUG codon (Kozak 1983). 
Next, the elongation phase is a cycle of aminoacyl-tRNA delivery and peptide bond formation 
until the process terminates with the nascent peptide release and ribosome dissociation (Mathews 
et al. 2007). Some mRNAs will be translated immediately, while others will be stored and 
shipped off to various cellular depots until they are needed, such as the leading edge of 
lamellipodia, mitotic spindles, and neuronal synapses (Besse and Ephrussi 2008; Holt and 
Bullock 2009); these stored  mRNAs are shipped and translationally repressed by RNA-binding 
proteins until they are locally translated by the ribosome. 
During the process of mRNA translation, initiation is the most rate limiting step (Lodish 
and Jacobsen 1972; Palmiter 1975). It is reasonable for translational initiation to be both rate 
limiting and the point at which general translation is arrested in an effort to conserve energy 
during times of cellular stress (Sonenberg and Hinnebusch 2009).  But what about the opposite 
scenario: Do specific mRNAs have translational precedence over one another and if so, how 
does this occur?  Because a given mRNA must be translated at the expense of a different mRNA, 
it seems highly plausible for cells to actively control not only general translation, but specific 
mRNA translation as well. Often, it is the complement of mRNA-associated RNA-binding 
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proteins that can promote or repress the translational capacity of a given mRNA though the 
mechanisms by which this occurs are not fully understood. 
The mRNA‟s lifecycle would not be complete without the death or decay of the mRNA. 
mRNA decay is initiated first by decapping, then 5‟ degradation or  3‟ degradation by RNA 
exonucleases, and ultimately complete nucleolytic destruction (Garneau et al. 2007; Goldstrohm 
and Wickens 2008). 
 
RNA-binding proteins: Master regulators of mRNA metabolism. 
 
mRNAs are constantly bound by a dynamic panel of RNA-binding proteins in the form of 
an mRNP. Surprisingly, of the ~800 putative RNA binding proteins in the human genome 
predicted by the identification of either an RNA recognition motif (RRM) or K Homology (KH) 
domain, little is known about the mechanisms of how this class of proteins may regulate mRNA 
localization, translation and/or mRNA stability (Sanchez-Diaz and Penalva 2006; Mathews et al. 
2007). However, it is generally acknowledged that translational control by RNA-binding proteins 
affords the cell an evolutionarily novel repertoire of exquisite control mechanisms; this allows 
for extensive innovation both spatially, as in the example of body patterning by Orb and Bruno 
during Drosophila development (Webster et al. 1997), and temporally, as in the example from 
oocyte maturation and translational control at the synapse for synaptic plasticity by the 
Cytoplasmic Element Binding Protein (CPEB) (Richter 2007). Translational control of specific 
mRNAs affords the cell additional control mechanisms including:  i) enables cells to quickly 
respond to extracellular cues as exemplified by the Xenopus oocyte, ii) a degree of flexibility by 
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allowing the reversible control of protein synthesis and associated high energy demands, 
exemplified by HuR (also known as Embryonic Lethal Abnormal Vision-like or ELAVL1) 
antagonism of microRNA-122 translation repression (Bhattacharyya et al. 2006) , iii) coordinates 
and organizes mRNAs into ontologically relevant mRNP units post-transcriptionally  
(Hieronymus and Silver 2004), and finally iv) preferential movement of mRNAs in and out 
polyribosomes (Proweller and Butler 1996).  
In the cytosolic compartment, the translation of one mRNA must come at the cost of 
translating another. RNA-binding proteins can influence this translational balance for specific 
mRNAs in many different ways. One such mechanism that enhances movement of specific 
mRNAs into translating polysomes, is the cytoplasmic polyadenylation of mRNAs. The poly(A) 
tail of an mRNA acts as a scaffold for RNA-binding proteins, such as the poly(A) binding 
protein PABP which promotes translation. Although the poly(A) tail is initially added in the 
nucleus, the length of this tail can be altered in the cytoplasm to affect the translational efficiency 
of specific mRNAs. A cis-element found in the 3‟-UTR of some mRNAs which stimulates 
polyadenylation is known as the cytoplasmic polyadenylation element (CPE) (McGrew et al. 
1989). The CPE is a binding platform for the CPE binding protein (CPEB)  which nucleates 
factors that can both remove and add poly(A) tails; experiments utilizing the Xenopus laevis 
oocyte detail mechanistically how CPEB can accomplish this feat (Barnard et al. 2004; Kim and 
Richter 2006).   
 
CPEB function in Xenopus laevis oocytes. 
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 Most metazoans undergo some sort of sexual reproduction. Specialized cells termed 
gametes arise from germ cells via meiosis. The gametes will fuse to form the zygote that quickly 
develops into the blastula. After blastulation, the embryo continues to differentiate into various 
organs and tissues and ultimately a mature individual. The two gametes, the sperm and ova, not 
only contribute genetic material, but a centrosome from the sperm and cytoplasm from the 
oocyte. The oocyte‟s cytoplasm supports early embryogenesis by supplying many factors, 
including some 1012 ribosomes and maternal mitochondria, as well as maternally derived 
mRNAs synthesized during oocyte development; these dormant mRNAs are required for both 
maturation of the oocyte and for early embryonic divisions, as these events proceed in the 
absence of transcription (Ferrell 1999). Transcription remains silenced for many cleavage cell 
divisions, until the mid-blastula transition (MBT), as in the African clawed frog Xenopus laevis 
and fruit fly Drosophila, but only two cell divisions in mice and up to eight in human. Whereas 
the cleavage divisions in mammals take two to three days, roughly one-tenth of the total 
gestation period in mice, eleven cleavage divisions will occur in seven hours in Xenopus (Gilbert 
1997). Thus, the maternally synthesized sets of transcripts are targets for multiple, most likely 
conserved, translational regulatory mechanisms responsible for generating the early embryonic 
proteome.  
 Oocytes from Xenopus laevis represent an ideal system amenable to biochemical 
dissection and experimentation to test paradigms of translational control and cell cycle 
regulation.  Early oocyte maturation in Xenopus laevis proceeds up to the dictyate stage of 
pachytene in prophase I where it then arrests; this arrest is comparable to a Growth-phase 2 (G2) 
arrest observed in somatic mammalian cells. Oocyte maturation is thus the process of 
hormonally-stimulated cell cycle resumption and meiotic-phase progression where the oocyte 
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reduces its genome from tetraploid to haploid in preparation for fertilization. Early experiments 
demonstrated that stores of select maternally derived mRNAs become translationally active upon 
progesterone stimulation; these mRNA were shown to enter the translating polyribosomal 
fractions by sucrose gradient sedimentation (Dworkin et al. 1985; McGrew et al. 1989). The 
entrance of mRNAs into the polysomal fraction is due to an increase in the mRNAs 3‟  poly(A) 
tail length  demonstrated by removing this tail by oligo(dT) + RNAse H (Richter 1991; Gray and 
Wickens 1998). Subsequent experiments by McGrew and Richter (1991) using serial deletion 
analysis of a reporter RNA sequence identified an AU-rich element required for progesterone 
induced polyadenylation and named it the Cytoplasmic Polyadenylation Element (CPE). The 
CPE, whose general consensus sequence is UUUUUAU, was also demonstrated to require an 
additional hexanucleotide sequence AAUAAA that had previously been shown to bind the CPSF 
complex (Shatkin and Manley 2000). Together, the CPE and hexanucleotide sequence are 
required for the increase in the reporter mRNA G10, previously identified to shift in size after 
progesterone treatment (McGrew et al. 1989). UV-crosslinking experiments led to the 
identification of the protein that binds the CPE: the CPE binding protein (CPEB) (Hake and 
Richter 1994). From the many experiments, mostly conducted in Xenopus laevis oocytes, four  
models of CPEB-mediated translational control emerge: i) the masking model (Figure 1), ii) the 
opposing deadenylation-polyadenylation model (Figure 2), iii) poly(A) tail stabilization model 
through ePAB (Figure 3), and iv) the CPE combinatorial code. The four models are historically 
distinct, but mechanistically overlapping and inter-dependent. 
 
The models of CPEB function. 
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 After identifying the cis-element and trans-acting factor required for cytoplasmic 
polyadenylation in frog oocytes, rigorous experimentation led to the identification of many other 
components of the CPEB-polyadenylation complex (Stebbins-Boaz et al. 1999; Mendez and 
Richter 2001; Barnard et al. 2004; Kim and Richter 2006; Kim and Richter 2007; Richter 2007).  
The underlying theme of how CPEB regulates translation is via polyadenylation-induced 
translation, but over the last twenty years four models of CPEB mediated translational control 
have emerged. Because, CPEB itself has no catalytic activity and is thus simply an RNA-binding 
protein, CPEB is merely the core of a complex of auxiliary enzymes that can reversibly inhibit 
and/or promote translation by adding or removing adenosine ribonucleotides to the 3‟ end of 
mRNA. CPEB-associated factors can also block eukaryotic initiation factor 4G (eIF4G) entry to 
prevent translational initiation (Richter 2007).  
As previously stated, translation is primarily limited by the rate of the initiating ribosome. 
Thus, by increasing the polyadenylate tail of mRNA, the poly(A) binding proteins (PABPs) are 
recruited and specifically bind polyadenylate stretches. These PABPs (of which there are at least 
four cytoplasmic isoforms in human cells) then form a protein-protein-protein bridge via PABP, 
eIF4G and eIF4E to promote the recruitment of the small ribosomal subunit and the ternary 
complex containing initiator methionine (Sonenberg and Hinnebusch 2009; Jackson et al. 2010) 
– creating the so called „cap to tail synergy‟ summarized by the closed loop model of translation 
(Sachs and Wahle 1993; Tarun et al. 1997). Initial co-immunoprecipitations using antibody 
against CPEB followed by mass-spectometry identified the eIF4E-binding protein Maskin, α-
helical triple coiled-coil protein, as a component of the CPEB-complex (Stebbins-Boaz et al. 
1999). One of the first models to emerge from these studies was the Masking-Model of 
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translational control (Figure 1). However, the mouse and human orthologue of Maskin TACC3 
does not contain any obvious eIF4E binding domain. Interestingly, another CPEB and eIF4E 
binding protein Neuroguidin (Ngdn), could possibly substitute in function for Maskin in 
mammals (Jung et al. 2006). 
 In the Xenopus oocyte, upstream signaling events initiated by progesterone binding to an 
as yet unidentified receptor generate a signal transduction cascade along with an increase in 
cyclic adenosine monophosphate (cAMP) cellular concentration that promotes the activity of 
Eg2 (Andresson and Ruderman 1998), the human orthologue of Aurora-A kinase. In its active 
state, the kinase Eg2 phosphorylates CPEB at serine residue 174 within the amino acid sequence 
motif LDSR (Mendez et al. 2000b). The phosphorylation of CPEB by Eg2 initiates the 
polyadenylation of stored dormant maternal mRNAs that have a short 3‟ tail of approximately 
twenty adenosines. CPEB itself cannot polyadenylate mRNA, thus predicting that CPEB must 
then either recruit additional factors, weaken its affinity for inhibitory factors (such as Maskin), 
or change the activity of a previously bound factor (for example, stimulate CPSF activity). 
Furthermore, the observation that almost all mRNAs receive a poly(A) tail before leaving the 
nucleus also predicts that a deadenylase must at some point interact with CPEB-bound mRNAs 
prior to CPEB phosphorylation, polyadenylation, and ensuing translation. Separate co-
immunoprecipitation experiments led to the identification of three additional factors residing in 
the CPEB complex: symplekin, a protein scaffold and tight junction protein (Barnard et al. 
2004), xGld-2(Barnard et al. 2004), a non-canonical poly(A) polymerase required for CPEB 
mediated polyadenylation in Xenopus, and PARN (Kim and Richter 2006), an enzyme 
possessing 3‟ RNA exonuclease activity. Thus, a model is suggested by the work of Kim and 
Richter (2006), whereby mRNAs transcribed in the nucleus of Xenopus oocytes are spliced and 
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polyadenylated, after which CPEB binds the mRNA and nucleates a complex containing: 
symplekin, maskin, CPSF complex, Gld-2 and PARN (Figure 2). CPEB then binds its target 
mRNA in the nucleus as experiments demonstrate CPEB can shuttle between cytoplasm and 
nucleus (Lin et al. 2010). CPEB-bound PARN then  deadenylates CPE-containing mRNAs and 
they lay dormant until activated by progesterone (Kim and Richter 2006). Because PARN 
presumably has overriding or greater deadenylating activity, PARN activity opposes the 
polyadenylation activity of Gld-2 in the cytoplasm until meiotic resumption and CPEB 
phosphorylation by Eg2. The phosphorylation of CPEB at the critical S174 residue then reduces 
the affinity of CPEB for PARN, thereby expelling PARN from the complex and ensuing default 
polyadenylation by Gld-2 (Kim and Richter 2006; Richter 2007). This model exemplifies one of 
the themes of translational control: translational control affords the cell with a poised and 
immediate response to extracellular cues (Mathews et al. 2007). Additionally, the presence of the 
deadenylase PARN in the CPEB-complex may guard against the precocious polyadenylation and 
translation of repressed mRNAs (Kim and Richter 2006). 
 After the initial events of Eg2 activation and phosphorylation of CPEB, Cdk1 complexes 
with cyclin B, an mRNA target of CPEB, to initiate the cell‟s embryonic cell cycle. Additional 
translational control mechanisms exist upstream or parallel to CPEB, namely derepression of 
RINGO/SPY mRNA by the RNA-binding protein Pumilio-2, to ensure rapid and robust cell 
cycle activation (Padmanabhan and Richter 2006; Vasudevan et al. 2006). However, stemming 
from the observation that CPEB becomes hyperphosphorylated in later stages of oocyte 
maturation (Mendez et al. 2002), Kim and Richter (2007) demonstrated that embryonic poly(A) 
binding protein (ePAB) is also bound to CPEB. ePAB, identified by both the Moon and Steitz 
groups (Zelus et al. 1989; Voeltz et al. 2001; Seli et al. 2005) further stabilizes the poly(A) tail 
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by disassociating from CPEB after CPEB hyperphosphorylation, presumably from proline 
directed Cdk1 phosphorylation sites (Mendez et al. 2002; Kim and Richter 2007). This release of 
ePAB from the complex may also concentrate ePAB and eIF4G, weakening Maskin affinity for 
eIF4E, and thus promoting eIF4F complex formation and translational initiation (Figure 3).  
 The final model of CPEB-regulated cytoplasmic polyadenylation involves an additional 
factor that binds another common cis-element in the 3‟-UTR of CPE containing mRNAs, the 
Pumilio Response Element (PRE) or Pumilio Binding Element (PBE). As previously discussed, 
the composition of the complex of proteins required for cytoplasmic polyadenylation is well 
characterized; however, the context of the CPEB complexes positioning on the 3‟-UTR of an 
mRNA is poorly defined (Charlesworth et al. 2004; Pique et al. 2008). Also, the observation that 
not all CPE-containing mRNAs are polyadenylated at the same time during oocyte development 
(Ballantyne et al. 1997; de Moor and Richter 1997; Mendez et al. 2002) suggests other cis-acting 
elements such as the Pumilio Binding Element (PBE) (Nakahata et al. 2003) may operate in 
parallel and organize mRNAs into functionally relevant sets (Hieronymus and Silver 2004; 
Licatalosi and Darnell 2010). Finally, very little is known about the identity of specific 
individual CPE containing mRNAs, but because many maternal CPE-containing mRNAs can be 
differentially polyadenylated temporally, additional sequence specific instructions residing in the 
3‟-UTR are predicted to dictate when, and perhaps where, CPE mRNAs are polyadenylated. Of 
course this control is beyond the scope of the CPEB-complex and is inextricably linked to the 
sequence context of the non-coding regions (5‟ and 3‟ UTRs) of specific mRNAs. 
 
CPEB family proteins. 
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 Most invertebrate and vertebrate metazoans have been shown to possess a CPEB or 
CPEB-like orthologue (Richter 2007). CPEB is most similar to Orb2 in the fly Drosophila 
melanogaster and Cbp-3 in the nematode Caenorhabditis elegans, maintaining a high degree of 
amino acid conservation, thus predicting a similar degree of functional conservation as well 
(Figure 5). Higher vertebrate metazoans have been shown to also contain three additional CPEB-
like proteins. Huang et al. (2006) used systematic evolution of ligands by exponential enrichment 
(SELEX) and structural probing experiments to demonstrate that CPEB4 has a preference for a 
structural cis-element and not a CPE-like sequence. Therefore, the CPEB4 binding  sequence is 
different from CPEB1 and most likely binds functionally distinct target mRNAs (Huang et al. 
2006). Very little is known about either the target mRNAs for CPEB2 and CPEB3 family 
member proteins or how CPEB2 or CPEB3 regulates these mRNAs. Further mechanistic 
elucidation of the function of CPEB family members CPEB2, CPEB3, and CPEB4 await 
experimentation. Interestingly, the Mendez Group recently demonstrated that CPEB4 can co-
immunoprecipitate xGld-2 poly(A) polymerase, and thus may be functionally similar to CPEB1 
polyadenylation complex (Igea and Mendez 2010) . 
 
Conservation of CPEB function in distant metazoans. 
 
 After a plethora of work done in the Xenopus oocyte, a CPEB-knockout mouse was made 
nearly a decade after the identification of the CPE (McGrew et al. 1989; Tay and Richter 2001). 
The initial impetus for the creation of the knockout (KO) mouse was to test whether CPEB was 
required for both meiotic and mitotic cell cycles. The prediction was that CPEB loss-of-function 
through complete gene ablation would result in a phenotype similar to that observed in mos-
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deficient mice:  a parthenogenetic activation of oocytes (Hashimoto et al. 1994). Mos, a 
serine/threonine kinase, is a cytosolic factor (CSF) that importantly initiates a MAP-kinase 
cascade that liberates Xenopus oocytes from meiotic arrest, but is also required for the arrest of 
meiosis at the end of metaphase II  (Sagata 1997). Oocytes of mos null animals have a high rate 
of spontaneous parthenogenetic activation and later develop ovarian cysts and tumor due to a 
failed ovulation (Colledge et al. 1994; Hashimoto et al. 1994; Choi et al. 1996). Importantly, mos 
is under control of CPEB in Xenopus oocytes (Stebbins-Boaz et al. 1996). Unexpectedly, female 
CPEB knockout mice, otherwise normal in appearance, have undetectable or vestigial ovaries 
(Tay and Richter 2001). Male CPEB knockout mice have disrupted spermatogenesis and suffer 
from hypogonadism (Tay and Richter 2001). Thus, both male and female CPEB knockout mice 
are sterile (Tay and Richter 2001).  
CPEB mRNA is also highly expressed in distinct regions of the mammalian brain (Theis 
et al. 2003). Experiments in the last decade in the field of learning and memory have shown a 
requirement of protein synthesis for strengthening synaptic efficacy during the early phase of 
learning (Schuman 1997). Fluorescence in situ hybridization (FISH) experiments demonstrated 
that CPEB mRNA was present in the dendritic layer of the hippocampus (Wu et al. 1998) and, 
intriguingly, Calmodulin Kinase II (CamKII), an important player essential for long-term 
potentiation (LTP) and neuronal differentiation, has CPEs in its 3‟-UTR (Wu et al. 1998). 
Importantly, the necessary components for local translation are also present in dendritic shafts 
and spines, such as ribosomes, initiation factors, and mRNAs (Eberwine et al. 2001; Job and 
Eberwine 2001). Thus, Wu et al. (1998) surmised neurons could recapitulate what had been 
previously shown in frog oocytes, that polyadenylation by CPEB could stimulate translation 
required for local protein synthesis and synaptic efficacy. Wu et al. (1998) demonstrated by 
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purifying synaptosomes from dark-reared animals, with and without visual stimulation from 
light, not only exhibit an increase of 1.7 fold in CamKII protein, but have an increase in poly(A) 
tail length. These findings are significant not only because they demonstrate that the CPEB-
mediated translational control mechanism found in frog oocytes is conserved between distant 
metazoans, but also because they show that other types of cells, such as polarized post-mitotic-
hippocampal neurons, can employ CPEB-mediated translational control under quite distinct 
circumstances. 
 As significant and interesting as the findings are that CPEB is involved in neurons and 
germ cell differentiation, CPEB KO mice are surprisingly normal (Richter 2007). One 
explanation for the lack of additional aberrant phenotypes in the CPEB KO mouse is that in the 
absence of CPEB1, the organism can compensate the loss-of-function with that of another CPEB 
family member protein. Compensation by other family member proteins is a common theme as 
demonstrated by the D-type cyclin family knockout mice (Ciemerych et al. 2002; Kozar et al. 
2004; Ciemerych and Sicinski 2005). Recent experiments from the Mendez group demonstrate 
that CPEB4 can bind the CPE, albeit with one-tenth the affinity. Igea and Mendez (2010) also 
demonstrate that important polyadenylation enzymes, such as the poly(A) polymerase Gld-2, can 
co-immunoprecipitate with CPEB4 (Igea and Mendez 2010). Regardless, because CPEB KO 
mice are sterile, a viable alternative to breeding the mice was to culture murine embryonic 
fibroblasts (MEFs) to further investigate the role of CPEB in somatic cell cycle (Groisman et al. 
2006). 
 
Cellular Senescence. 
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 Primary murine embryonic fibroblasts (MEFs) proliferate normally in cell culture for up 
to five passages when they then begin to experience a cell cycle arrest between passages five 
through eight. This proliferative cell cycle arrest has been termed cellular senescence in mice and 
is generally thought to occur as the result of cell culture stress from abnormally high levels of 
20% atmospheric oxygen in comparison to the 4% normally found in most tissues (Parrinello et 
al. 2003). However, senescence is now generally accepted as bona fide tumor-suppressor 
mechanism important for prevention of malignant tumors (Collado et al. 2005; Collado and 
Serrano 2005). Senescence has a wide range of triggers from Reactive Oxygen Species (ROS) 
and DNA damage – presumably due to high oxygen levels and UV-damage –  to the aberrant 
expression of oncogenes, improper cellular contacts, lack of nutrients, inflammatory cytokines, 
and telomere decapping (Ben-Porath and Weinberg 2004).  
The initial master regulator of senescence onset is p53, then the retinoblastoma protein 
(Rb) (Dimri 2005). When cultured by the standard 3T3 protocol (300,000 cells, trypsinize, 3 
days), CPEB KO MEFs surprisingly did not senesce but instead continued to proliferate and 
were immortal (Groisman et al. 2006). CPEB lacking a zinc finger, and thus deficient in the 
ability to bind RNA, cannot rescue senescence. However, CPEB reintroduction by way of viral 
transduction at early, but not late passages, can rescue senescence. These experiments thus 
demonstrate that CPEB is required for senescence onset. Groisman et al. (2006) further 
demonstrated that in cells lacking CPEB, the oncogene c-MYC is abnormally expressed at high 
levels, by both western-blot and by measuring the movement of c-MYC mRNA from 
monoribosomes to polyribosomes in CPEB WT versus KO MEFs. Groisman et al. (2006) further 
showed that the aberrant expression of c-MYC is sufficient for senescence bypass in MEFs. As 
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noted by the Mendez laboratory, the possibility of CPEB complex acting as a repressor of 
translation is consistent with the sequence context of c-MYC mRNA in that it has PBE 
sequences in close proximity to CPE‟s (Pique et al. 2008). However, it is open to 
experimentation to determine if this possibility is in fact true. 
 Senescence in murine cells is quite different than that of human cells. Credited as one of 
the first to rigorously investigate the finite lifespan of cultured cells, Leonard Hayflick in the 
1960‟s proposed that cells possess some sort of counting mechanism that prevents them from 
proliferating indefinitely and that this in turn is somehow related to organismal aging (Shay and 
Wright 2000). Later, it was shown that telomere erosion was one such counting mechanism 
(Stewart et al. 2003; Stewart and Weinberg 2006). Because MEFs generated from 
laboratoryoratory mice have constitutively active telomerase, the RNP responsible for 
maintaining and lengthening telomeres, this excludes the possibility that telomere erosion is 
important in the senescence of MEFs, or rather the lack of senescence in CPEB KO MEFs. Also 
different in mice and human cells is that human cells are more resistant to transformation. As 
compared to human cells, fewer genetic lesions are required to transform mouse cells (Hahn 
2002; Itahana et al. 2004).  Therefore, important questions remained as to the requirement of 
CPEB for senescence in human cells. 
 The next two chapters of this dissertation are thus concerned with the investigation of 
CPEB function in human somatic cells. In Chapter 2, CPEB loss-of-function studies were 
undertaken by knocking down CPEB mRNA in primary foreskin fibroblasts (hFS), in order to 
assess the importance of CPEB in human cellular senescence. Here we show that human cells 
lacking CPEB have impaired senescence resulting in a lifespan extension of nearly five-fold, and 
have maintained telomeres (Burns and Richter 2008). Similar to the findings in mouse cells, 
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CPEB can rescue senescence at early, but not late passages. Where perhaps different from MEFs, 
however, was the finding that human cells lacking CPEB had decreased mitochondrial numbers 
and corresponding ROS production and a compensatory increase in lactate production. 
Importantly, a CPEB-dependent translational defect of the p53 tumor suppressor protein mRNA 
was also found. Starting with the finding that CPEB is required for both normal senescence onset 
and polyadenylation of p53 mRNA, Chapter 3 then continues to describe initial attempts to 
recapitulate the findings from Xenopus oocytes by confirming the requirement for the predicted 
non-canonical poly(A) polymerase Gld-2 for the normal polyadenylation of the CPEB targeted 
mRNA of  p53. What follows details the unexpected findings that Gld-2 is surprisingly not 
required for p53 mRNA, but is instead an upstream regulator of CPEB mRNA translation by 
microRNA mediated translational repression. 
Because roughly one-third to one-fourth of human genes contain at least one putative 
CPE motif, understanding the molecular function of the CPEB cytoplasmic polyadenylation 
complex in normal somatic cells is as crucially important as it has been demonstrated for oocyte 
maturation, embryonic development, learning and memory. The mRNA binding protein CPEB 
seems to be less conserved in its regulatory amino-terminal end, but is highly conserved in its 
RNA binding domains, suggesting that CPEB target genes are most likely also conserved (Figure 
4). By identifying a novel CPEB-complex member and demonstrating regulatory features of 
CPEB mRNA translation within the biologically relevant context of cellular senescence, the 
findings presented in this dissertation have advanced our understanding of the critical functions 
of CPEB in human cells. 
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SUMMARY 
 
Cytoplasmic Polyadenylation Element Binding Protein (CPEB) stimulates 
polyadenylation and translation in germ cells and neurons.  Here, we show that CPEB-regulated 
translation is essential for the senescence of human diploid fibroblasts.  Knockdown of CPEB 
causes skin and lung cells to bypass the M1 crisis stage of senescence; re-introduction of CPEB 
into the knockdown cells restores a senescence-like phenotype.  Knockdown cells that have 
bypassed senescence undergo little telomere erosion.  Surprisingly, knockdown of exogenous 
CPEB that induced a senescence-like phenotype results in the resumption of cell growth. CPEB 
knockdown cells have fewer mitochondria than wild type cells and resemble transformed cells 
by having reduced respiration and reactive oxygen species (ROS), normal ATP levels, and 
enhanced rates of glycolysis.  p53 mRNA contains cytoplasmic polyadenylation elements (CPEs) 
in its 3‟ UTR, which promote polyadenylation.  In CPEB knockdown cells, p53 mRNA has an 
abnormally short poly(A) tail and a reduced translational efficiency, resulting in about a 50% 
decrease in p53 protein levels. An shRNA-directed reduction in p53 protein by about 50% also 
results in extended cellular lifespan, reduced respiration and ROS, and increased glycolysis. 
Together, these results suggest that CPEB controls senescence and bioenergetics in human cells 
at least in part by modulating p53 mRNA polyadenylation-induced translation. 
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INTRODUCTION 
 
Initiation is the rate-limiting step for translation of most eukaryotic mRNAs and requires 
both a 5‟ methylated guanosine cap (m7G[5‟]ppp[5‟]N) and a 3‟ poly(A) tail.  The ends of the 
RNA are brought into close proximity by a protein-protein-protein bridge composed of eIF4E 
(the cap binding factor), eIF4G, and poly(A) binding protein (PABP) (Tarun and Sachs 1996; 
Tarun et al. 1997; Wells et al. 1998).  PABP may facilitate the interaction of eIF4G with eIF4E, 
which is necessary for initiation since eIF4G, via the multisubunit eIF3, positions the 40S 
ribosomal subunit on the 5‟ end of the mRNA (Sonenberg and Hinnebusch 2007).  One mode of 
translational control that is particularly important for germ cell development is the abrogation of 
this 5‟-3‟ protein bridge by the near absence of the poly(A) tail (and hence PABP) and by the 
association of a specialized eIF4E binding protein with some mRNAs.  These inert (masked) 
mRNAs are activated by subsequent poly(A) tail growth the binding of PABP to poly(A), and 
the replacement of the eIF4E binding protein with eIF4G.  The cytoplasmic polyadenylation 
element (CPE) controls poly(A) tail length; it resides in mRNA 3‟ UTRs and serves as the 
binding site for CPEB, a factor that associates with Gld2, a poly(A) polymerase (Barnard et al. 
2004), PARN, a deadenylating enzyme (Kim and Richter 2006), ePAB, a poly(A) binding 
protein (Kim and Richter 2007), Maskin, an eIF4E binding protein (Stebbins-Boaz et al. 1999; 
Cao et al. 2006), CPSF, a multi-subunit RNA binding complex (Mendez et al. 2000b; Dickson et 
al. 2001), and symplekin, a probable scaffold or assembly protein (Barnard et al. 2004).  In 
response to developmental cues, CPEB becomes phosphorylated, causing the expulsion of 
PARN from the RNP complex and results in Gld2-catalyzed polyadenylation (Mendez et al. 
2000b; Kim and Richter 2006).  The newly elongated poly(A) tail is bound by ePAB that in turn 
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binds eIF4G; this complex displaces Maskin from eIF4E, thus circularizing the RNA and 
promoting initiation (Barnard et al. 2005; Cao et al. 2006; Kim and Richter 2006). 
CPEB-controlled translation has also been found to modulate neuronal synaptic plasticity 
(Klann and Richter 2007; Richter 2007) and cellular senescence in murine embryonic fibroblasts 
(MEFs) (Groisman et al. 2006).  Like apoptosis, senescence is a mechanism that prohibits 
unrestricted cell proliferation.  DNA damage, nutrient deprivation, improper cell contacts, and 
oncogenic signaling all converge on the p53 and/or retinoblastoma (Rb) tumor suppressor 
pathways to initiate cell cycle arrest and entry into senescence (Lowe et al. 2004; Campisi and 
d'Adda di Fagagna 2007).  While senescence is usually examined in cultured cells, recent studies 
in animals have demonstrated that it is an important barrier to malignant transformation (Braig et 
al. 2005; Chen et al. 2005; Collado et al. 2005; Michaloglou et al. 2005). 
The bypass of senescence, or immortalization, is required for but does not necessarily 
lead to cellular transformation.  Although both phenomena are often studied in mouse and human 
cells, there are a number of differences between the two organisms, indicating the complexity of 
molecules that influence these processes.  For example, cultured mouse cells are relatively easy 
to transform, requiring the addition of only one or two oncogenes (Drayton and Peters 2002).  
Normal diploid human cells, however, are more refractory and require the inactivation of the p53 
and Rb proteins as well as the activation of the catalytic subunit of the telomerase, hTERT.  In 
addition, mouse telomeres are typically 25-60 kb in length while those in humans are much 
shorter, about 10-15 kb; thus, telomere erosion is not necessarily essential for senescence in 
mouse cells while it is in human cells (Chin et al. 1999).  Moreover, murine cells senesce 
abruptly in culture 5-10 times faster than human cells.  These and other differences between 
mouse and human cells notwithstanding, it is increasingly evident that in both species, cellular 
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and replicative senescence are not only triggered by cellular perturbations that generate a DNA 
damage response, such as oncogene expression and cell culture stress (Lee et al. 1999; Wu et al. 
2004), but that senescence onset and maintenance requires a sustained DNA damage response 
(Hemann and Narita 2007). 
While comparing rates of mitosis between MEFs derived from wild type (WT) and CPEB 
knockout (KO) mice, we made the startling observation that the KO MEFS did not senesce as 
did WT MEFs, but instead were immortal (Groisman et al. 2006).  Reintroduction of CPEB into 
early passage KO MEFs induced them to senesce; reintroduction of CPEB into late passage KO 
MEFs (i.e., those that had gone through several passages beyond when WT MEFs senesce) did 
not.  CPEB-mediated senescence required the tumor suppressors p53 and p19ARF; conversely, 
Ras-induced senescence required CPEB.  Myc protein levels were elevated in the KO MEFs and 
more myc mRNA was found on polysomes compared to WT MEFs.  Most importantly, shRNA 
knockdown of myc in the KO MEFs caused them to become senescent.  These data indicated 
that in mouse cells, the removal of CPEB-inhibited myc RNA translation led to immortalization. 
Here, we investigate the importance of CPEB for senescence of normal human diploid 
fibroblasts.  While WT and mock-infected human foreskin fibroblasts senesced after about 70 
population doublings, those infected with a lentivirus harboring a shRNA against CPEB did not; 
the lifespan of these cells was extended by nearly five-fold.  A second infection of these 
knockdown cells with a retrovirus expressing murine CPEB restored a senescence-like 
phenotype in early but not late passage cells.  Human WI-38 lung fibroblasts also bypassed 
senescence when CPEB levels were reduced.  As expected, CPEB knockdown cells that 
bypassed senescence retained long telomeres.  Interestingly, promotion of the senescence-like 
phenotype by overexpressed CPEB could be reversed when the levels of this protein were 
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reduced.  CPEB knockdown cells had abnormally low levels of mitochondria; they also resemble 
transformed cells in that they had reduced respiration but an elevated rate of glycolysis 
presumably to maintain homeostatic ATP levels.  CPEB knockdown cells contained ~50% 
reduction of p53, and p53 mRNA had a shorter poly(A) tail and a reduced translational 
efficiency compared to p53 mRNA in wild type cells.  A ~50% reduction of p53 levels in cells 
containing normal levels of CPEB also bypassed senescence and had reduced mitochondrial 
mass and respiration. We propose that the senescence bypass and change in energy metabolism 
observed in CPEB knockdown cells is due at least in part to dysfunctional p53 mRNA 
polyadenylation and translation. 
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RESULTS 
 
CPEB is required for senescence in primary human cells 
 
 To determine whether primary human cells require CPEB to become senescent, human 
diploid foreskin fibroblasts were, in two separate occasions, infected at passage eight with a 
lentivirus expressing one of two different shRNAs against CPEB RNA (shCPEB) as a control for 
possible off-target effects.  As an additional control, the cells were also infected with an empty 
lentivirus or one expressing shRNA against mRNA encoding the tetracycline resistance gene 
(shTETR).  The lentivirus vector also expressed GFP, which indicated that ~70% of cells were 
infected with the virus.  The cells were analyzed for growth and morphology without drug 
selection. 
 The efficiency of the CPEB knockdown was monitored by both RT-PCR of RNA (data 
not shown) and by western analysis (Fig. 1A).  CPEB was reduced by greater than 80% 
compared to the control shTETR knockdown; the upper band in the panel might represent 
phosphorylated CPEB.  After ~68 population doublings, the mock-infected and shTETR-infected 
cells stopped dividing and assumed a flat senescent-like morphology.  These cells also stained 
for ß-galactosidase activity at acid pH, a common marker for senescence (Itahana et al. 2007) 
(Fig. 1D, and data not shown). The shCPEB-infected cells, however, continued to grow, did not 
undergo a morphology change, and did not stain for ß-galactosidase activity (Fig. 1A and D).  
Moreover, while mock-infected and shTETR-infected cells expressed high levels of p21CIP1 and 
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p16INK4A, which is consistent with entry into senescence, the cells infected with shCPEB did not 
(data not shown and Fig. 5).  
 Cells expressing shCPEB were infected with a retrovirus expressing mouse CPEB, which 
while >95% identical to human CPEB, would not be a target of the human shCPEB.  When the 
cells were infected with the retrovirus after 20 or 68 doublings, they quickly entered a 
senescence-like state as indicated by the cessation of cell division, assumption of flattened 
morphology, and staining for ß-galactosidase activity.  However, when the cells were infected 
with the retrovirus after 87 population doublings, none of these events took place.  Thus, the 
reintroduction of CPEB into knockdown cells induces a senescence-like state at early and 
middle, but not late, passages. 
 We also assessed whether CPEB is required for senescence in WI-38 human lung 
fibroblasts.  These cells were infected with the same lentiviruses used for the foreskin 
fibroblasts; while the mock infected or control infected cells entered senescence after an 
additional ten population doublings, those with reduced levels of CPEB did not and indeed 
reached at least 38 doublings (Fig. 1B).  Thus, at least two human cell types require CPEB to 
enter senescence. 
Finally, the zinc finger of CPEB was deleted, which in addition to containing two RNA 
recognition motifs, is required for CPE binding (Hake et al. 1998).  This mutant protein was 
unable to restore senescence (a mock infection also did not rescue senescence) (Fig. 1C-E).  
Therefore, CPEB must bind RNA to induce the senescence-like phenotype. 
 
CPEB is required for the suppression of telomere maintenance 
29 
 
 
 
 Because senescence in human cells is generally accompanied by telomere loss, we 
measured telomere length in cells infected with shCPEB by a telomere oligonucleotide ligation 
assay (T-OLA) (Stewart et al. 2003) and by fluorescence in situ hybridization (FISH) (Henegariu 
et al. 2001). The T-OLA assay (Fig. 2A, B) shows that as expected, the telomeres of WT or 
shTETR infected cells eroded as the cells entered senescence.  While the shCPEB-infected cells 
also underwent some telomere shortening (e.g., at 90 days post-infection), the erosion was not as 
severe as with the control cells.  This maintenance of telomere length was also evident by FISH 
for the telomeric region (Fig. 2C).  That is, at 90 days post-infection with shCPEB, there was 
clearly hybridization to the telomeric region.  In contrast, cells infected with shTETR underwent 
extensive telomere erosion as evidenced by the lack of a FISH signal to this same region.  As 
expected, WT cells also lacked a FISH signal due to telomere shortening.  These data indicate 
that CPEB is required, directly or indirectly, for telomere erosion. 
 
The CPEB-induced senescence-like arrest is reversible 
 
 Two approaches were used to determine whether the CPEB-induced senescence-like 
phenotype is reversible.  First, WT fibroblasts were infected with lentivirus expressing human 
HA-CPEB on day one, which was followed two days later by the infection of another lentivirus 
expressing shRNA against this same CPEB; the cells were analyzed four days later (Fig. 3A).  
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Western analysis shows that the shRNA efficiently knocked down HA-CPEB (Fig. 3B).  As 
expected, shCPEB, shGFP (another control), or mock lentivirus infections had no effect on cell 
growth when the cells were also infected with a retrovirus expressing CPEB lacking a zinc finger 
(hCPEB∆ZF), which is unable to bind RNA, or with a retrovirus that expressed no heterologous 
protein (mock) (Fig. 3C).  However, while retrovirally transduced CPEB efficiently attenuated 
cell growth as shown previously (see Fig. 1), the cells returned to prolific cell division once 
CPEB was knocked down by the lentivirus-expressed shCPEB (Fig. 3C). 
 In a second approach to address reversibility, sequences encoding a CPEB-GFP fusion 
protein were cloned into a vector containing the tetracycline response element.  Following 
infection and antibiotic selection, the cells were infected with a lentivirus encoding the 
tetracycline repressor (TetR); several days later, the cells were incubated with doxycyclin (DOX), 
which will repress the expression of CPEB.  The cells were then split; some were further 
incubated with DOX while others were transferred to DOX-free medium (-DOX).  The cells 
were analyzed 4 and 8 days later (Fig. 3D).  Fig. 3E demonstrates that CPEB (-DOX) inhibited 
cell division; conversely, the subsequent down-regulation of CPEB expression (+DOX) allowed 
the cells to continue to divide.  Finally, CPEB-GFP was readily detected in cells incubated in the 
presence, but not the absence, of DOX (Fig. 3F).  These results demonstrate that the CPEB-
induced senescence-like phenotype is reversible. 
 
CPEB is necessary for stress-induced cellular senescence 
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 Cellular senescence is generally thought to be a response to stresses that induce telomere 
shortening, oncogene activation, reactive oxygen species (ROS), etc. (Ben-Porath and Weinberg 
2005).  In MEFs, at least one inducer of senescence, constitutively activate Ras, requires CPEB 
(Groisman et al. 2006).  This is also the case with human fibroblasts that have reduced CPEB 
levels (Supplementary Fig. 1).  Also, as in CPEB KO MEFs, Ras failed to induce senescence in 
human fibroblasts with reduced CPEB (Supplementary Fig. 1).  Because Ras is involved in 
modulating levels of reactive oxygen species (ROS) (Irani et al. 1997; Archer and Bar-Sagi 
2002), we used two approaches to examine whether ROS was also involved in the CPEB-
induced senescence-like phenotype.  First, WT fibroblasts were treated with 200 M N-acetyl-
cysteine (NAC), an oxygen free radical scavenging agent, followed by infection of a retrovirus 
expressing CPEB.  While CPEB strongly induced senescence in untreated cells, its ability to do 
so in NAC-treated cells was substantially reduced (Supplementary Fig. 2A).  Moreover, 
fibroblasts treated with hydrogen peroxide to increase the ROS concentration readily senesced, 
but did not do so when they had reduced CPEB levels (Supplementary Fig. 2B). 
 While indirect, these results suggest some connection between CPEB and ROS, and 
possible changes in cellular bioenergetics.  To examine bioenergetics directly, we measured 
mitochondrial respiration in two CPEB knockdown cell lines; Fig. 4A shows that relative to WT 
or shTETR control cells, mitochondrial respiration in these cells was reduced by about 50%.  To 
investigate the origin of this reduced respiration, we stained WT, shTETR, and shCPEB cells 
with Mitotracker, which reflects mitochondrial mass, followed by stacking of confocal images.  
These images indicate that shCPEB caused a reduction of mitochondrial number (Fig. 4B); the 
quantification of the Mitotracker fluorescent signal indicates that there was nearly eight fold 
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fewer mitochondria (Fig. 4C).  This decrease was confirmed by a western blot for cytochrome C, 
a mitochondrial marker (Fig. 4D). 
 Because mitochondrial oxidative phosphorylation generates most of the cell‟s ATP, it 
might be inferred that the CPEB knockdown fibroblasts contain less ATP than WT cells.  
However, the level of ATP was nearly identical between WT and shCPEB cells (Fig. 4E).  
Transformed cells also have reduced respiration but maintain relatively normal levels of ATP by 
increasing glycolysis (Bensaad and Vousden 2007).  To determine whether this is also the case 
with CPEB knockdown cells, the amount of lactate, an indicator of glycolysis, was determined.  
Indeed, the CPEB knockdown cells produced about five times more lactate than did WT cells 
(Fig. 4F), indicating a substantial up-regulation of glycolysis.  Finally, CPEB knockdown cells 
were also found to have a decrease in ROS levels (Fig. 4G), as might be expected from the 
reduction in mitochondrial respiration. 
 
CPEB-induced senescence requires p53 
 
 In MEFs, CPEB requires p53 to induce senescence (Groisman et al. 2006), 2006).  To 
determine whether this is also the case with human cells, fibroblasts were infected with a 
retrovirus expressing GSE-22, a p53 dominant negative peptide that inhibits p53 activity 
(Beausejour et al. 2003). Two days later, the cells were infected with a virus expressing CPEB; 
the cells were then analyzed for growth and p21, a target gene of p53 (Figs. 5A-C).  While CPEB 
induced senescence in cells lacking GSE-22, they were unable to do so if they contained the 
inhibitory peptide.  Moreover, GSE-22 prevented p21 expression, thus demonstrating that it 
33 
 
indeed inhibited p53 activity.  These results indicate that CPEB-induced senescence requires p53 
in human cells. 
 
CPEB control of p53 mRNA translation 
 
 Several senescence-related proteins were analyzed in extracts derived from WT, shTETR, 
and shCPEB cells.  p53 as well as K382-acetylated p53 were reduced by about 50-60% in 
shCPEB-containing cells; the cell cycle inhibitory proteins p21CIP1 and p16INK4A were also 
reduced, consistent with the bypass in senescence (Fig. 6A).  Because p53 mRNA levels were 
not commensurately lower with the p53 protein levels (Fig. 6B), we inferred that CPEB might 
control, directly or indirectly, the post-transcriptional regulation of p53.  One indication that this 
regulation might be direct is the fact that two conserved CPEs are found in the 3‟ UTRs of p53 
mRNA from several mammalian species (Fig. 6B).  To examine whether these CPEs are 
functional, radiolabeled RNA corresponding to the p53 3‟UTR was injected into Xenopus 
oocytes, followed by incubation with progesterone, which stimulates oocyte maturation and 
CPE-dependent polyadenylation.  Indeed, the p53 3‟UTR underwent robust polyadenylation. 
Moreover, a p53 3‟UTR with mutated CPEs exhibited little polyadenylation (Fig. 6C), 
demonstrating that the p53 3‟UTR has the proper sequences to promote cytoplasmic 
polyadenylation.  In transfected fibroblasts, HA-tagged wild type CPEB, but not a CPEB with 
deleted zinc fingers, efficiently co-precipitated p53 mRNA; GAPDH mRNA, a negative control 
was not precipitated under any condition (Fig. 6E).  Finally, we investigated whether a 
knockdown of CPEB would alter the poly(A) tail length of p53 mRNA.  Fig. 6F shows a PCR-
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based PAT assay (Salles and Strickland 1995) for poly(A); while the poly(A) tail of p53 RNA 
reached nearly 200 nucleotides in WT cells, it was only about ~50 nucleotides in shCPEB 
knockdown cells.  Thus, CPEB controls p53 RNA poly(A) tail length in human fibroblasts. 
Because p53 protein levels are maintained by a balance of synthesis and destruction, we 
sought to determine which of these processes was controlled by CPEB.  WT and shCPEB-
infected fibroblasts were first starved of methionine and cysteine, then pulsed with 35S-
methoinine and 35S-cysteine, followed by a chase with radio-inert methionine and cysteine.  p53 
was then immunoprecipitated and the decay of this protein was monitored by SDS-PAGE and 
phosphorimaging.  While shCPEB had no effect on the decay rate of general cellular proteins, 
there was a stabilizing effect on p53 (Fig. 7A,B).  This result, however, is complicated by the 
fact that p53 is a positive regulator of the human homologue of mdm2, the E3 ligase that controls 
ubiquitin-mediated p53 destruction (Fig. 7C). In other words, elevated p53 levels induce mdm2 
transcription, which in turn leads to p53 destruction.  Consequently, we have used alternative 
approaches to determine why p53 levels are reduced in CPEB knockdown cells.  First, WT and 
shCPEB infected cells were pulsed with 35S-methonine and 35S-cysteine in the presence of the 
proteasome inhibitor MG132, followed by p53 immunoprecipitation.  Compared to total protein, 
the rate of p53 synthesis was ~50% lower in the shCPEB-infected cells compared to WT (Figs. 
7D, E).   
The translational efficiency of p53 mRNA was determined by polysome sucrose density 
centrifugation of extracts from WT and shCPEB-infected cells.  The gradients were fractionated 
and following RNA extraction, p53 mRNA was assayed by Q-RT-PCR using GAPDH mRNA as 
an internal standard.  Fig. 7F demonstrates that in shCPEB-infected cells, there was a shift in the 
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sedimentation profile of p53 mRNA from heavy to lighter polysomes, consistent with a reduction 
in translational efficiency. 
  
Senescence bypass and alteration in bioenergetics in p53 knockdown cells 
 
We next investigated whether the ~50% reduction in p53 in CPEB knockdown cells is 
sufficient for the senescence bypass and change in bioenergetics (Fig. 8A). To do so, we stably 
expressed a p53 shRNA via lentiviral gene transfer, which reduced p53 protein levels by about 
50% (Fig. 8B).  As expected, expression of p21, a p53 target gene, was also inhibited (Fig. 8B).  
The 50% reduction of p53 induced senescence bypass, as did expression of the GSE-22 
dominant negative p53 peptide (Fig. 8C).  The 50% reduction of p53 also resulted in reduced 
mitochondrial respiration (Fig. 8D) and ROS (Fig. 8E), and stimulated a greater than 6 fold 
increase in lactate production, indicating substantial up-regulation of glycolysis (Fig. 8F).  To 
assess what factors might be downstream of CPEB and p53 that influences the change in 
bioenergetics, we determined the levels of synthesis of cytochrome oxidase 2 (SCO2), which has 
been reported to modulate the Warburg effect in a p53-dependent fashion (Matoba et al. 2006).  
Fig. 8F demonstrates that SCO2 levels were reduced in cells in which either CPEB or p53 were 
knocked down, suggesting that the influence of CPEB on bioenergetics occurs via p53 mRNA 
translation and SCO2. 
 
Response to chemical carcinogen in CPEB knockout mice 
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Based on the results of Groisman et al (2006) and this study that describe the importance 
of CPEB in cell growth and metabolism in vitro, we have initiated studies to examine the relative 
importance of CPEB in ageing and malignant transformation in mice.  CPEB knockout mice 
have ~2-2.3 year lifespans that are virtually indistinguishable from those of wild type animals; 
they also display no unusual proclivity for tumor formation (data not shown).  However, CPEB 
KO mice do form papillomas at a significantly faster rate than wild type animals in a two-step 
DMBA-TPA carcinogenesis assay (Supplementary Fig. 3).  Thus, CPEB does appear to offer 
some protection against at least one type induced tumor formation and perhaps other induced 
stresses as well. 
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DISSCUSSION 
 
 We demonstrate that reduced levels of CPEB cause a bypass of senescence in primary 
human cells.  While these cells have a nearly five-fold extended lifespan, their rate of cell 
division eventually begins to slow and they cease to divide after about 93 population doublings.  
While mouse cells (MEFs) that lack CPEB also bypass senescence, they do not begin to slow 
even after >40 passages and are immortal (Groisman et al. 2006).  In both mouse and human 
cells lacking (or with reduced) CPEB, the re-introduction of CPEB at early passages restores a 
senescence-like phenotype; a similar re-introduction of CPEB into late passage cells, however, 
has little effect on cell division.  While it is unclear why only early passage cells respond to 
exogenous CPEB, such experiments do demonstrate that it is CPEB and not another factor that is 
responsible for the senescence bypass.  In both MEFs and human fibroblasts, p53 is required for 
CPEB-induced senescence while CPEB is required for Ras-induced senescence ((Groisman et al. 
2006); Fig. 5; Supplementary Fig. 1).  These similarities between mouse and human cells 
notwithstanding, CPEB-controlled senescence in MEFs is mediated at least in part by myc while 
in human cells, one key factor is p53.  In MEFs containing or lacking CPEB, there is no 
detectable change in the amount of p53 over many cell passages while myc protein is elevated in 
CPEB KO MEFs (Groisman et al. 2006). Myc mRNA is also translated more efficiently in the 
KO MEFs and is at least one factor that mediates immortalization when CPEB is absent since a 
knockdown of myc in CPEB KO MEFs causes a cessation of cell division (Groisman et al. 
2006).  In human skin fibroblasts, there is no evidence for CPEB control of myc translation that 
contributes to senescence.  On the other hand, CPEB mediates poly(A) tail length and 
translational control of p53 mRNA.  Without the translational enhancement of p53 mRNA by 
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CPEB, p53 levels are reduced to less than half their normal levels, which leads to senescence 
bypass (Fig. 8; see also (Rogan et al. 1995; Wei et al. 2003; Lynch and Milner 2006) and 
changes in bioenergetics (see below). 
  Our results indicate that CPEB controls p53 mRNA polyadenylation and translation, 
possibly in a manner similar to that which occurs in vertebrate germ cells (Tay and Richter 2001; 
Tay et al. 2003; Barnard et al. 2004; Kim and Richter 2006; Richter 2007).  If this is the case, 
then other factors such as Gld2 and PARN, which mediate CPEB-directed polyadenylation in 
oocytes, may have the same function in human fibroblasts, and a reduction in their steady state 
levels might modulate senescence.  
 In response to DNA damage, ribosomal protein L26 (rpL26) has been reported to 
stimulate p53 mRNA translation while nucleolin inhibits it (Takagi et al. 2005). p53 mRNA 
translation in also enhanced by the RNA binding protein HuR in response to UV irradiation 
(Mazan-Mamczarz et al. 2003).  While we have no evidence that CPEB regulates p53 mRNA 
translation in response to DNA damage, it appears to regulate steady state translation by insuring 
that the p53 poly(A) tail is the proper length.  Polyadenylation is a complex process regulated in 
both the nucleus and cytoplasm.  For example, both nuclear pre-mRNA and cytoplasmic mRNA 
polyadenylation can be regulated during the cell cycle (Colgan et al. 1996; Groisman et al. 2006) 
and in response to certain signaling events (Wu et al. 1998; Mellman et al. 2008).  Moreover, 
poly(A) dynamics are also regulated by environmental stress (Hilgers et al. 2006) and by 
miRNAs (Wu et al. 2006).  We speculate that CPEB activity may be necessary for maintaining 
steady state p53 levels under normal conditions where it has important functions in cellular 
ageing and energy metabolism (Bensaad and Vousden 2007). 
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Reversible CPEB-induced senescence-like phenotype 
 
 The observation that the CPEB-induced senescence-like phenotype was reversible was 
surprising because senescence is generally considered to be an irreversible process.  On the other 
hand, there have been reports of senescence reversibility under particular circumstances.  For 
example, (Macip et al. 2006) have shown that in p53 null cells, a reactive oxygen species-
induced senescence-like phenotype is reversible.  This type of senescence reversibility may not 
be directly related to that described here since oxidative stress of CPEB knockdown cells does 
not readily induce senescence (Supplementary Fig. 2).  Moreover, Beausejour et al. (2003) have 
shown that senescence accompanying telomere shortening can also be reversed. While the nature 
of the CPEB reversibility of senescence requires further investigation, it is clear that cells‟ entry 
into senescence is particularly sensitive to the amount of this protein.  That is, in human cells, a 
knockdown of CPEB, either endogenous or exogenous, to ~20% of normal levels results in 
senescence bypass.  In MEFs, cells heterozygous for CPEB also bypass senescence (Groisman et 
al. 2006).  Conversely, cells containing relatively low amounts of exogenous CPEB require 
several passages before they senesce whereas cells containing high levels senesce much faster.  
We speculate that the amount of CPEB is important for the relative translational efficiency of 
p53 mRNA, which in turn could be responsible for the rate, or timely onset, of senescence. 
 
CPEB, p53, and energy metabolism 
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CPEB knockdown fibroblasts have nearly eight fold fewer mitochondria compared to 
WT cells and overall, respire about half as well.  This startling observation suggests that these 
cells have reduced ATP levels and thus would probably divide more slowly than wild type cells.  
Such is not the case, however, because knockdown cells have a very high rate of glycolysis; 
normal levels of ATP are therefore generated and the cell division rate at early passages is 
indistinguishable from wild type.  The so-called „Warburg effect‟ of reduced oxygen 
consumption and elevated glycolysis was recognized many years ago as a hallmark of cancer 
cells (Shay and Wright 2000; Gatenby and Gillies 2004; Bensaad and Vousden 2007). Based on 
the Warburg effect, it might be inferred that CPEB knockdown skin fibroblasts are transformed; 
this is unlikely to be the case, however, because they are contact inhibited (data not shown).  
Moreover, the CPEB KO MEFs do not grow in reduced serum, do not show significant 
anchorage independent growth, and do not form tumors when injected into nude mice (Groisman 
et al. 2006).  In the human CPEB knockdown fibroblasts, it seems likely that the Warburg effect 
is due to reduced levels of p53 (Fig. 8; (Matoba et al. 2006).  In p53 null or even hypomophic 
cells, aerobic respiration is reduced and glycolysis is elevated.  One downstream gene whose 
expression was recently reported to be regulated by p53, synthesis of cytochrome oxidase 2 
(SCO2), may be responsible for several of these changes in energy metabolism (Matoba et al. 
2006).  This protein is necessary for assembly of the multi-protein cytochrome C oxidase (COX) 
complex, which forms the molecular foundation for oxidative phosphorylation.  Indeed, SCO2 is 
reduced in CPEB as well as p53 knockdown cells (Fig. 8), which probably is responsible for the 
lowered respiration and elevated glycolysis. However, there are likely to be a number of mRNAs 
whose translation is mis-regulated in cells that lack CPEB, some of which are likely to contribute 
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to the senescence bypass and/or the Warburg effect.  In this vein, (Wajapeyee et al. 2008) 
recently identified a growth factor, IGFBP7, and 16 additional factors that control BRAF-
induced senescence.  In MEFs, CPEB is necessary for Ras and probably BRAF-induced 
senescence, suggesting that mRNAs encoding some of these factors might be under the 
translational control of CPEB.  We are presently investigating whether the translational 
regulation of other mRNAs modulates senescence. 
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Materials and Methods 
 
Cells and culture conditions 
 
Primary human foreskin fibroblasts were obtained from the Cell Culture Core Facility of 
the Yale University Skin Disease Research Center and cultured as described (Rangarajan et al. 
2004) in Dulbecco‟s Modified Eagle‟s Medium (DMEM) containing 10% fetal calf serum.  
About 106 cells, counted with a hemocytometer following treatment with trypan blue, were 
passaged every three days.  Human lung WI-38 fibroblasts were cultured in a similar manner. 
 
Virus production, infection, and cell lines 
 
Amphotropic retroviruses and lentiviruses were produced by transient transfection of 
293T cells with a transfer vector and amphotropic packaging plasmids encoding VSV-G and 
gag-pol using Lipofectamine 2000 (Invitrogen). Human cells at 50% confluency were infected 
for 8-12 hr with viral supernatants containing 7μg/ml polybrene. Typically 70-90% infection 
efficiency was achieved as assessed by using a GFP-encoding viral gene or by immunostaining 
cells using anti-HA (Covance). After infection, fresh media was added to the infected fibroblasts. 
 Some cells were analyzed by western blotting for p16 (BD Biosciences), p21 (Santa Cruz 
Biotechnology), p53 (DO-1, Neomarkers), CPEB (Affinity BioReagents), cytochrome C (BD 
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Pharmingen), SCO2 (Dr. Paul M. Hwang, NHLBI-NIH), and b-actin (Abcam).  Other cells were 
fixed with 0.2% glutaraldehyde and stained for b-galactosidase activity at acidic pH according to 
Dimri et al (1995). 
 
Telomere Analysis 
 
A telomere oligonucleotide ligation (TOLA) assay was performed as previously 
described (Stewart et al. 2003).  Briefly, DNA extracted from WT, shTETR, and shCPEB 
infected cells (5 mg each) was added to a 20 ml reaction volume containing 0.5 pmol 32P-end-
labeled (CCCTAA)4 oligonucleotide and hybridized for 12-15 h at 50 °C followed by addition of 
20 units Taq DNA ligase (New England Biolabs) at 50 °C for 5 h.  After ligation, the DNA was 
precipitated, dried, resuspended and applied to a 5% polyacrylamide-6 M urea gel.  To ensure 
equal DNA loading of TOLA gels, 10 ng of each TOLA sample was analyzed by Q-PCR for the 
GAPDH gene.  Primer sequences are presented in the Supplemental material. 
Metaphase chromosomes from WT, shTETR, and shCPEB infected cells were prepared 
as described (Henegariu et al. 2001) and blocked with COT1 DNA and hybridized with 50 ng of 
a locked nucleic acid (LNA) probe (TTAGGGTTAGGGTTAGGG; locked nucleotides are 
underlined) that was 3‟ end conjugated with Cy3.   
 
RNA analysis 
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To examine the p53 mRNA poly(A) tail, total RNA (300 ng) was pre-annealed with 5-
prime phosphorylated oligo d(T)18 (20 ng/ml) followed by reverse transcription (RT) with an 
oligo d(T)18 anchor primer (5‟-GCTTCAGATCAAGGTGACC-d(T)18).  Subsequent PCR used 2 
ml from the previous RT with primers specific for p53 RNA and the linker in the presence of 
dNTPs plus 32P-ATP.  Details can be found in the Supplementary material. 
Immunoprecipitation of mRNA-protein complexes was performed on early passage 
fibroblasts infected with virus encoding HA-CPEB (Peritz et al. 2006), followed by RT-PCR for 
p53 and GAPDH mRNAs. 
 
Analysis of p53 
 
Control and shCPEB infected fibroblasts were cultured in methionine and cysteine-free 
media (Invitrogen) for 45 min and then cultured in media containing 140 mCi 35S methionine 
and 35S cysteine (ProMix, Amersham) for 30 min.  The cells were then washed and cultured in 
fresh DMEM supplemented with 2 mM each of methionine and cysteine for the times indicated.  
The cells were then frozen and stored until they were lysed and used to immunoprecipitate p53 
(DO-1 antibody, Neomarkers), which was analyze by SDS-PAGE and phosphorimaging.  Details 
of the procedure may be found in the Supplementary material.  
 Some cells were cultured in methionine/cysteine free media as noted above in the 
presence of MG132, a proteasome inhibitor, for 1 hr, followed by a 15 min culture in 100 mCi 
35S methionine and cysteine; p53 was then immunoprecipitated and analyzed as noted above. 
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Bioenergetics 
 
To measure oxygen consumption, ~4x105 cells were washed and resuspended in 200 ml 
Krebs-Ringers solution plus HEPES (125 mM NaCl, 1.4 mM KCl, 20 mM HEPES, pH 7.4, 5 
mM NaHCO3, 1.2 mM MgSO4, 1.2 mM KH2,PO4, 1 mM CaCl2) containing 1% BSA.  Cells 
from each condition were aliquoted into a BD Oxygen Biosensor System plate (BD Biosciences) 
in triplicate.  Plates were assayed on a SAFIRE multimode microplate spectrophotometer 
(Tecan) at 1-minute intervals for 60 minutes at an excitation wavelength of 485 nm and emission 
wavelength of 630 nm.  
 
Lactate assay 
 
The concentration of lactate in 40,000 cells was measured as described by Chang et al 
(1992); the NADH produced by the conversion of lactate to pyruvate by lactate dehydrogenase 
was measured at 340nm using a SAFIRE multimode spectrophotometer (TECAN). 
 
ATP 
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ATP concentrations were determined using a CellTiter-Glo Luminescent Cell viability 
assay kit (Promega) by first plating approximately 40,000 cells in 96 well format plate and 
following the manufacturer‟s instructions. 
 
Mitochondria 
 
Images were obtained from live cells plated on coverslips after incubating them with 
500nM Mitotracker-Red (Molecular Probes).  Cells were stained cells for 20 min. in 10% FBS, 
DMEM, 5% CO2 using a Zeiss AxioVert 200M Confocal with a PerkinElmer UltraView 
Spinning Disc. Images were analyzed with Metamorph and Imarus software, similar to (Kang et 
al. 2007). 
 
ROS 
 
 ROS levels in 80,000 cells were determined by using 10 mM CM-H2DCFDA 
(dichlorodihydrofluorescein diacetate) (Invitrogen) in Krebs-Ringer bicarbonate buffer (Sigma-
Aldrich).  Using a Tecan plate reader, CM-H2DCFDA was excited at 485 nm and detected at 530 
nm with a 4x4 pattern reader. 
 
Detailed procedures 
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 Details of all procedures can be found in the supplementary material. 
 
Supplemental Experimental Procedures 
 
Virus production, infection, and cell lines 
 
Amphotropic retroviruses and lentiviruses were produced by transient transfection of 293T cells 
with the appropriate transfer vector and amphotropic packaging plasmids encoding VSV-G and 
gag-pol using Lipofectamine 2000 (Invitrogen).  Both mouse and human cells at ~60% 
confluency were infected for 8-12 hr with viral supernatants containing 7 μg/ml polybrene.  
Typically, 70-90% infection efficiency was achieved using this protocol as assessed by GFP 
fluorescence with a GFP-encoding virus or HA staining with a virus expressing HA-CPEB.  
After infection, fresh media was added to the cells. 
 
SA-β-galactosidase assay 
 
Cells were fixed with 0.2% glutaraldehyde (Sigma) and incubated 12 hr at 37C in a filtered 
solution containing 1 mg/ml X-Gal (Sigma) in 150 mM NaCl, 2 mM MgCl2, 5 mM K3Fe(CN)6, 
5 mM K4Fe(CN)6, and 40 mM sodium phosphate buffer (pH 6.0).  
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Ligation mediated poly(A) test (LM-PAT), Xenopus oocyte injection and poly(A) test (PAT) 
 
For the analysis of poly(A) of p53 mRNA, 5 μg of total RNA was extracted using Trizol reagent 
and annealed to oligo d(T)18-linker (500 μg/ml; 5′-GCGAGCTCCGCGGCCGCGT18-3′);  
dNTPs were added, followed by a further incubation at 65°C for 5 min.  After quick chilling on 
ice, reverse transcription was performed with Superscript II (Invitrogen) according to the 
manufacturer‟s instructions. p53-specific oligomers and oligo d(T)18-linker, and 1 μl of cDNA 
template were used in a 25 μl PCR reaction with PlatinumTaq (Invitrogen).  Trace amounts of 
32P-dATP was added to the PCR reactions.  The PCR products were digested with a p53-specific 
exonuclease BstXI (New England Biolabs) to ensure p53 specific amplification and analyzed on 
polyacrylamide gels. 
 Oocyte injections and progesterone induced polyadenylation assay was performed as 
previously described (McGrew et al. 1989). 
 
IP-RT-PCR 
 
Immunopreciptiation of mRNA-protein complexes was performed on early passage fibroblasts 
infected with the amphotropic virus expressing c-pOZ CPEB-HA. The procedure was performed 
according to Peritz et al (2006). The following gene specific primers were used for RT reactions 
and subsequent PCR. 125ng DNAse treated total RNA was used for RT reactions. One μl of RT 
mix was used for 25 PCR cycles.  The following primers were used; GAPDH forward primer 5‟-
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CGCTCTCTGCTCCTCCTGTT; GAPDH reverse primer 5‟-CCATGGTGTCTGAGCGATGT; 
P53 forward primer 5‟-TCTTGCATTCTGGGACAGCC; p53 reverse primer 5‟-
AGCTCGTGGTGAGGCTCCCCT. 
 
Polyribosome gradients 
 
Extracts derived from infected cells were used for polysome gradient centrifugation as prepared 
as described by Ruan et al (1997).  Briefly, fibroblasts cells cultured in 10-mm culture dishes 
were harvested 24 h after transfection by replacing the culture media with fresh media containing 
cycloheximide (Sigma) at a final concentration of 100 μg/ml for 5–10 min.  The cells were 
washed with PBS, trypsinized, pelleted and resuspended in low-salt buffer (20 mM Tris-HCl (pH 
7.5), 10 mM NaCl, 3 mM MgCl2).  Triton-X 100 was added to the cell suspension to a final 
concentration of 0.3% (v/v) and the cells were lysed on ice using a 1-ml Dounce homogenizer.  
The solution was centrifuged for 1 min at 10,000xg at 4 °C and the supernatants were layered on 
top of linear 15%–50% (w/v) sucrose gradients (11 ml).  Centrifugation was carried out in a 
Beckmann SW41Ti Rotor at 36,000 r.p.m. for 2 h at 4°C.  Polysome profiles were monitored by 
absorbance of light with a wavelength of 254 nm (A254).  
 
Quantitative PCR 
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Trizol regent (Invitrogen) was used to extract RNA from 400 μl polysome fractions from 
fibroblasts processed as described above.  The RT reactions were performed with Superscript II 
(Invitrogen) using 1 or 5 μl RT mix,.  Quantitative PCR reactions were conducted using Sybr 
Green PCR MasterMix (Qiagen) on an ABI 7700 real time thermocycler.  The primers used for 
PCR and RT are described above. 
 
Lactate assay 
 
40,000 cells were plated in a 6-well tissue culture plate (BD Biosciences); one day later, they 
were washed and suspended in 250 μl PBS before addition of HCl to a final concentration of  
0.03 N HCl.  The cells were then frozen at -20 C until use..  Thawed cells were suspended in 
50μl of 400 mM 2-amino-2-methylpropanol (Sigma), pH 9.9.  A 4 ml assay cocktail containing 1 
ml 400mM glutamate, pH 9 in 10mM PBS, 1 ml 15mM -nicotinamide adenine dinucleotide 
(Sigma), pH6.5 in 10 mM PBS, 2 ml 10mM PBS.  A typical assay included 40μl assay cocktail, 
100μl sample or lactate standards (to a generate standard curve).  Using a Tecan plate reader, 
absorbance of 340nm light prior to incubation with enzymes was performed.  Twenty microliters 
of enzyme cocktail (200 U/ml L-lactate dehydrogenase and 80 U/ml glutamic-pyruvic 
transaminase in 10mM phosphate buffer, pH 6.5) was then added and the mixture was incubated 
20 min at room temperature; absorbance at 340nm light was then measured. 
 
Metabolic p53 labeling and immunoprecipitation 
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350,000 cells per 6mm plate were cultured for 30-45min in 5% dialyzed FCS in methionine and 
cysteine free media (Invitrogen); 140 μCi 35S Met/Cys (ProMix, Amersham) was then added and 
the cells were cultured for 30 min.  The radioactive media was removed and the cells cultured in 
DMEM  with 10% FBS, DMEM and 2mM each of cysteine and methionine.  The cells were then 
washed with 2 ml ice-cold PBS, centrifuged, and stored frozen until use.  The cells were 
suspended in  100 μl 50 mM Tris, pH 7.5, 1% SDS, 5 mM DTT, boiled for  10 min and the 
insoluble material pelleted.  To the supernatant was added 1.2ml 50 mM Tris, pH7.5, 250 mM 
NaCl, 5 mM EDTA, 0.5 NP-40, and protease inhibitors (complete protease inhibitor, 
BohringerManhiem).  A  50 μl slurry of protein A Sepharose was then added and rotated in cold 
room for 1 hour.  The beads from this pre-clearing step were then removed and 1 μl p53 DO-1 
antibody was added and the mixture rotated for 1 hr. in a cold room.  A 50 μl slurry of protein A 
Sepharose was added to samples and rotated for 1 hour.  The samples were then centrifuged 
briefly and to the supernatant was added additional p53 antibody and protein A Sepharose.  The 
immunoprecipitation procedure was repeated two more times; the beads were then combined and 
resuspended with 100 μl SDS gel laoding buffer for analysis by electrophoresis and 
phosphorimaging.  
 
In other experiments, 3.5 x 106 cells were cultured in methionine and cysteine-free media as 
above, but were also treated with 50 μM MG132 for 1 hr.  The cells were then labeled in 35S 
methionine and cysteine-containing media for 15 min prior to p53 immunopreciption. 
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Figure 1. CPEB is necessary for cellular senescence.   
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Figure 1. CPEB is necessary for cellular senescence.  (A)  Human foreskin fibroblasts were 
infected with a lentiviruses encoding shRNA targeting CPEB mRNA (shCPEB), or the 
tetracycline resistance mRNA (shTETR), as a control.  Additional cells were mock infected with 
an empty lentivirus.  Population doublings were then determined by counting cells with a 
hemocytometer.  Some cells were also infected with a retrovirus expressing mouse CPEB 
(because of differences in the primary sequence, mouse CPEB mRNA is not a target of the 
shCPEB), followed by cell counting.  The inset shows a western blot probed for CPEB and actin; 
these extracts were prepared from cells 40 days post-lentivirus infection.  (B)  Human lung 
fibroblasts (WI-38) were infected with lentiviruses targeting CPEB or, as a control GFP; mock 
refers to infection with an empty virus.  The cells were counted as in part A.  (C and D)  Foreskin 
fibroblasts previously infected with shCPEB were also infected with retroviruses expressing wild 
type CPEB or a CPEB lacking a zinc finger, which renders the protein incapable of RNA 
binding.  Some cells were also mock infected.  The cells were then stained for b-galactosidase at 
acid pH and were counted (panel C), and visualized by bright field microscopy three days after 
retrovirus infection (D). 
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Figure 2. CPEB knockdown cells retain long telomeres   
56 
 
Figure 2. CPEB knockdown cells retain long telomeres.  (A)  DNA was extracted from skin 
fibroblasts infected with shCPEB and shTETR-containing lentiviruses 20, 50, or 90 days post-
infection and used to determine telomere length by the telomere oligonucleotide ligation assay 
(TOLA).  (B)  The relative telomere lengths derived from the analysis in panel A were quantified 
by scanning desitometry.  (C)  shCPEB, shTETR, and noninfected wild type (WT) cells were 
fixed at 90 days post-infection and used for fluorescence in situ hybridization to telomeric 
regions (telo-FISH) using a Cy3-conjugated locked nucleic acid oligonucleotide (LNA).  The 
DNA was stained with DAPI. 
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Figure 3.  The CPEB-induced senescence-like phenotype is reversible. 
  
58 
 
Figure 3.  The CPEB-induced senescence-like phenotype is reversible.  (A)  Schematic 
representation of one sequence of events used to examine the reversibility of the CPEB-induced 
senescence-like phenotype.  (B)  Western blot for CPEB and tubulin derived from fibroblasts 
that were sequentially infected with a retrovirus encoding HA-tagged human CPEB (hCPEB-
HA) followed by a lentivirus encoding shCPEB (two different sequences) or shGFP.  (C)  Cell 
numbers were determined following sequential infection of the viruses noted in panel A. (D)  
Schematic representation of the experimental timeline when cells were infected with a retrovirus 
expressing CPEB under the control of the tetracycline repressor.  Skin fibroblasts were infected 
with a virus expressing a CPEB-GFP fusion protein under the control of the Tetracycline 
Response Element (TET-ON), followed the next day by puromycin selection.  Three days later, 
the cells were infected with a virus encoding the tetracycline repressor (TETR); the cells were 
then cultured for several days in the presence of doxycyclin (DOX), which allows GFP-CPEB 
expression to remain high.  Some cells were then cultured in medium lacking DOX, which will 
repress GFP-CPEB transcription.  (E)  Growth chart of 2 cell lines containing exogenous CPEB-
GFP under control of the TETr cultured in the absence or presence of DOX.  (F)  Live cell 
images of GFP-CPEB containing cells cultured in the absence or presence of DOX. 
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Figure 4. Reduced respiration and mitochondrial number in CPEB knockdown cells.    
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Figure 4. Reduced respiration and mitochondrial number in CPEB knockdown cells.  (A)  
Fibroblasts infected with shCPEB (targeted to two different sequences), shTETR, or empty virus 
(mock) were cultured for approximately 47 days when they were used to measure oxygen 
consumption.  (B)  Z-plane stacks of confocal images obtained from live cells, some of which 
were infected with shCPEB or shTETR, stained with MitotrackerRed to visualize mitochondria.  
(C)  Quantification of MitotrakerRed fluorescence from panel B.  (D)  Immunoblot of 
cytochrome C from WT, shTETR, and shCPEB infected cells.  A nonspecific immuno-reactive 
band served as a loading control.  (E)  WT, shCPEB, and shTETR cells were used to measure 
ATP concentration.  (F)  Lactate, a indicator of glycolysis, was determined in shCPEB (targeting 
two different sequences) and control cells. (G)  Determination of relative ROS levels in cells 
expressing shCPEB or shTETR.  
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Figure 5.  CPEB induced senescence requires p53.    
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Figure 5.  CPEB induced senescence requires p53.  (A)  Fibroblasts were infected with a 
retrovirus expressing GSE-22, a p53 dominant negative peptide.  Two days later, the cells were 
infected with a virus harboring CPEB; examination of the cells began on day 7.  (B)  Growth 
curves of GSE-22 or CPEB-infected or mock infected cells.  (C)  Western blot analysis of p21 
and tubulin in infected or mock infected cells. 
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Figure 6.  CPEB promotes cytoplasmic polyadenylation of p53 mRNA. 
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Figure 6.  CPEB promotes cytoplasmic polyadenylation of p53 mRNA.   (A)  Extracts from 
shCPEB shTETR, or mock infected cells were probed with antibodies specific for p53, K382 
acetylated p53, p21CIP1, p16INK4A, and actin.  (B)  The amount of p53 protein in panel A was 
quantified by densitometry, and the amount of p53 RNA in other infected cells was quantified by 
Q-RT-PCR; the ratios of these values was then plotted.  (C)  Diagram of the salient features of 
the p53 mRNA 3‟ UTRs from several mammals; the CPEs and AAUAAA hexanucleotide are in 
bold.  The bottom sequence denotes dinucleotide substitutions in each of the two CPEs.  (D)  The 
human WT and mutated p53 3‟ UTRs were radiolabeled and injected into Xenopus oocytes, 
which were then treated with progesterone to induce meiotic maturation and cytoplasmic 
polyadenylation.  (E)  Fibroblasts infected with a retrovirus encoding HA-CPEB or HA-CPEB 
lacking the zinc finger were used for HA antibody co-immunoprecipitation and RT-PCR 
detection of p53 mRNA and the non-CPE-containing GAPDH mRNA.  (F)  Ligation-mediated 
polyadenylation test (LM-PAT) assay was used to estimate the poly(A) tail length of p53 mRNA 
in WT and shCPEB knockdown cells.   
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Figure 7. CPEB controls p53 mRNA translation. 
  
66 
 
Figure 7. CPEB controls p53 mRNA translation.  (A and B)  WT and shCPEB infected cells 
were incubated in methoinine and cysteine-free medium for 30 minutes, followed by an 
incubation with 35S-methionine and 35S-cysteine for 30 minutes and then an incubation of up to 
45 minutes with excess radioinert methionine and cysteine.  p53 was immunoprecipitated from 
the extracts at 0, 15, and 45 minutes of the amino acid chase and resolved by SDS-PAGE, as was 
total cell protein.  (C)  Diagram illustrating a feedback loop where high levels of p53 induce 
transcription of the E3 ligase mdm2, which in turn induces p53 destruction.  Ub refers to 
ubiquitin.  (D and E)  WT and shCPEB infected cells were incubated in methionine and cysteine 
free media for 1 hour followed by incubation in 35S-methionine and 35S-cysteine for 15 minutes.  
p53 was then immunoprecipitated and analyzed by SDS-PAGE and phosphorimaging.  The 
quantification of p53 levels in three different experiments is shown.  (F)  Extracts from WT and 
shCPEB-infected fibroblasts were centrifuged through 15-50% sucrose gradients, fractionated, 
and scanned with 254 nm light.  The relative amounts of p53 and GAPDH mRNAs were 
quantified by Q-RT-PCR.  A representative polysome profile (absorbance at 254 nm light)  from 
wild type cells is shown. 
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Figure 8.  p53 regulation of senescence and bioenergetics.  
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Figure 8.  p53 regulation of senescence and bioenergetics.   (A)  Proposed pathway in which 
CPEB, at least in part, influences senescence, telomere maintenance, and bioenergetics.  (B)  
Western blot showing a shRNA-directed~50% knockdown of p53, which inhibits the expression 
of p21.  (C)  Growth curves of wild type cells or cells infected with shp53 or GSE-22. (D)  
Oxygen consumption in cells infected with a non-silencing shRNA, shp53 RNA, or GSE-22, a 
p53 inhibitory peptide.  (E)  Relative ROS levels in wild type or shp53 infected cells.  (F)  Levels 
of lactate in wild type and shp53 knockdown cells.  (G)  Western blot of SCO2 in CPEB and p53 
knockdown cells. 
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Supplementary Figure 1.  Ras requires CPEB to induce senescence. (A) Cells passaged for 32 
days were infected with a retrovirus containing RASV12; two days post-infection, GFP-positive 
cells were scored for flat senescent-like morphology. 
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Supplementary Figure 2.  Oxidative stress-induced premature senescence requires CPEB. (A) 
primary human foreskin fibroblasts were mock infected or infected with retroviruses expressing 
CPEB or CPEB∆ZF.  The resulting cultures were then split and sister cultures were treated with 
200 M N-acetyl cysteine (NAC).  The cells were then stained for SA--galactosidase activity 
and counted. (B)  WT and shCPEB and shTETR infected cells were treated with 150 M H2O2 
for two hours after which they were washed with PBS and grown in normal growth media 
overnight.  The cells were then stained for SA--galactosidase activity. 
71 
 
 
 
 
 
 
 
  
Supplementary Figure 3.  CPEB requires p53 activity to induce senescence. (A) Schematic 
diagram to describe the order in which cells were infected with different viruses.  Human 
fibroblasts were infected with a lentivirus encoding GSE-22, a dominant negative form of p53, or 
CPEB.  The cells were then infected two days later with other viruses encoding CPEB or GSE-
22.  (B)  Growth chart demonstrating that two cell lines continue to proliferate irrespective of 
when they express CPEB. 
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SUMMARY 
 
The cytoplasmic polyadenylation element binding protein (CPEB) nucleates a complex of 
factors on specific mRNA 3‟ untranslated regions to regulate polyadenylation-induced 
translation. Gld2 is a non-canonical poly(A) polymerase that interacts with CPEB to catalyze 
polyadenylation. Because p53 mRNA polyadenylation/translation is controlled by CPEB in 
primary human diploid fibroblasts, we surmised that Gld2 would be the enzyme responsible for 
poly(A) addition.  Surprisingly, depletion of Gld2 promoted p53 mRNA 
polyadenylation/translation, as well as enhanced the stability of CPEB mRNA.  Using mRNA 
reporters containing the CPEB 3‟UTR, two sequences, which correspond to miR-122 binding 
sites, were found to regulate translation, as did an antagomir of miR-122.  Although miR-122 is 
thought to be liver-specific, it is present in human primary fibroblasts but destabilized by Gld2 
knockdown.  Further experiments demonstrate that Gld4 is the CPEB-associated poly(A) 
polymerase that regulates p53 mRNA polyadenylation/translation. Thus, p53 mRNA 
translational homoeostasis is maintained by a regulatory hierarchy composed of Gld2/miR-
122/CPEB/Gld4. 
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INTRODUCTION/RESULTS 
 
 Cytoplasmic polyadenylation-induced translation controls germ cell development 
(Mendez et al. 2000a; Tay and Richter 2001), neuronal synaptic plasticity (Wu et al. 1998; 
Alarcon et al. 2004; Zearfoss et al. 2008), and cellular senescence (Groisman et al. 2006; Burns 
and Richter 2008), a tumor-suppressor mechanism that limits the replicative lifespan of cells 
(Stewart and Weinberg 2006; Campisi and d'Adda di Fagagna 2007). Although polyadenylation 
is mediated by several factors three core ones are CPEB, a sequence-specific RNA binding 
protein that specifies which mRNAs undergo polyadenylation; Gld2, a poly(A) polymerase, and 
PARN, a deadenylating enzyme.  Poly(A) tail length is governed by the interaction of PARN 
with the ribonucleoprotein (RNP) complex: when PARN is associated with the RNP, the poly(A) 
tail is short because its deadenylating activity overrides the polyadenylating activity of Gld2.  
When PARN dissociates from the RNP complex following signal-induced CPEB 
phosphorylation, the poly(A) tail is lengthened by constitutively-active Gld2 (Barnard et al. 
2004; Kim and Richter 2006; Kim and Richter 2007).  
 Mouse embryo fibroblasts (MEFs) derived from CPEB knockout (KO) mice do not 
senesce as do MEFs derived from wild type (WT) mice, but instead are immortal.  Senescence is 
rescued when ectopic CPEB is expressed in the KO MEFs and potentiated when expressed in 
WT MEFs (Groisman et al. 2006).  Human foreskin fibroblasts depleted of CPEB bypass 
senescence and divide ~270 days compared to WT cells that senesce after about 90 days.  As 
with the mouse cells, ectopic expression of CPEB rescues senescence in knockdown cells and 
potentiates senescence in WT cells. CPEB controls the polyadenylation-induced translation of 
p53 mRNA, and indeed CPEB-induced senescence requires p53.  Depletion of CPEB also 
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induces the “Warburg Effect” where mitochondrial respiration is reduced and cells produce ATP 
primarily though glycolysis (Burns and Richter 2008).   
 To investigate the possibility that CPEB control of p53 polyadenylation would require 
Gld2, human primary foreskin fibroblasts were stably transduced with lentiviruses expressing 
two different shRNAs against the Gld2 coding sequence.  Surprisingly, Gld2 depletion (Fig. 1a, 
1b) elicited an increase in both p53 protein levels (Fig. 1c) and p53 mRNA polyadenylation (Fig. 
1d).  Also unexpectedly, depletion of Gld2 resulted in increased oxygen consumption (Fig. 1e) 
and entry into a senescence-like cell cycle arrest as evidenced by ß-galactosidase staining at acid 
pH (Fig. 1f).  In comparison, CPEB depleted cells had decreased oxygen consumption, fewer 
cells staining with ß-galactosidase, increased lifespan, and most importantly, reduced poly(A) 
tail size on p53 mRNA and a 50% reduction in p53 protein levels (Burns and Richter 2008). 
These paradoxical results prompted us to examine CPEB levels in Gld2 depleted cells 
because CPEB is required for normal p53 mRNA translation (Burns and Richter, 2008).  After 
comparing the levels of CPEB nuclear pre-mRNA by intron-specific qPCR and mostly 
cytoplasmic mRNA by exon-specific qPCR, we found that although the pre-mRNA levels, which 
generally reflect transcription, were nearly unchanged, cytoplasmic mRNA levels increased by 
about two-fold (Fig. 2a).  Thus, in the absence of Gld2, CPEB mRNA unexpectedly was more 
stable. 
 Surmising that Gld2 might control p53 protein levels via CPEB, we next used a Renilla 
luciferase (Rluc) and firefly luciferase (Fluc) reporter system to investigate post-transcriptional 
regulation of CPEB by Gld2.  As shown in Figs. 2b and 2c, a knockdown of Gld2 resulted in 
nearly an 80% increase in RLuc expression as well as when the 3‟ most 455 nucleotides of the 
CPEB 3‟ UTR were deleted.  By comparison, expression of the reporter harboring either the full 
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length CPEB 3‟ UTR or a 3‟ deletion was unaffected in Gld2 knockdown cells (Fig. 2c).  
Additional serial deletions of the distal CPEB 3‟ UTR demonstrated that there were two regions, 
encompassing nucleotides 300-480 and 480-560, which elicited increases in reporter translation 
following Gld2 knockdown; moreover, the repression mediated by these two regions was 
additive (Fig. 2d). 
 Analysis of the two regions of the CPEB 3‟ UTR that mediated translational repression 
by Gld2 revealed the presence of two potential miR-122 binding sites (Supplemental Figure 1).  
Although miR-122 is thought to be liver-specific and account for ~70% of the total population of 
microRNAs in that tissue (Lagos-Quintana et al. 2002), deletion of these specific sites, either 
individually or combined, nonetheless alleviated translational repression in a dose-dependent 
manner in Gld2 depleted cells (Fig. 3a), and were nearly identical to that observed with the large 
deletions (Fig. 2d).  These results suggest that miR-122 might repress CPEB mRNA translation 
in human skin fibroblasts and indicate that this miRNA might be more widely distributed than 
originally thought.  Indeed recent evidence shows that miR-122 is present in human skin (Holst 
et al. 2010) and even HEK293 cells (Liao et al. 2010).   
 To assess directly whether miR-122 might repress CPEB mRNA expression, cells were 
electroporated with a locked nucleic acid (LNA) antagomir for miR-122, or as a control, a 
scrambled LNA.  The miR-122 antagomir enhanced reporter expression by nearly 4.5 fold 
relative to control (Fig. 3b).  Importantly, when miR-122 LNA antagomir-transduced cells were 
pulsed labeled with 35S-methionine for 15 min followed by p53 immunoprecipitation and 
analysis by SDS-PAGE and phosphorimaging, there was a two-fold increase in the synthesis of 
p53 protein (Fig. 3e).  These data indicate that human primary skin fibroblasts contain miR-122 
and that Gld2 controls its steady state levels or activity.  Fig. 3c indeed demonstrates that these 
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cells do contain miR-122 and that Gld2 knockdown reduces the level of this miRNA by nearly 
40 fold.  These results are consonant with those of Katoh et al (2008), who demonstrated that in 
liver, Gld2 is essential for miR-122 stability. 
While consistent with the hypothesis that miR-122 mediates p53 mRNA translation via 
CPEB, these data do not eliminate the possibility that miR-122 could act via another molecule to 
regulate p53 synthesis (note that p53 mRNA has no miR-122 site according to Targetscan.org or 
Microrna.org).  Consequently, we infected cells with a lentivirus expressing shRNA for CPEB as 
well as the miR-122 antagomir followed by a 15 minute pulse of 35S-methinie pulse and p53 
immunoprecipitation.  Fig. 3f shows that although miR-122 antagomir alone induced an increase 
in p53 synthesis, the antagomir plus shRNA for CPEB elicited to increase.  Taken together, these 
data demonstrate that Gld2 activity stabilizes miR-122, which in turn reduces CPEB expression; 
CPEB then acts directly on p53 mRNA to mediate poly(A) tail length and translation. 
 If not Gld2, what poly(A) polymerase works with CPEB to modify p53 mRNA 
polyadenylation and translation? We thought that a non-canonical poly(A) polymerase, i.e., one 
that lacks an RNA binding domain and thus would require another factor such as CPEB to be 
tethered to the RNA, would most likely be involved.  Two cytoplasmic enzymes have this 
characteristic, Gld4 (PAPD4) (Schmid et al., 2008) and MitoPAP (PAPD1) (Mullen and 
Marzluff, 2008).  Both polymerases were depleted with shRNAs (data not shown), but only the 
loss of Gld4 reduced p53 translation (Fig. 4a) and polyadenylation (Fig. 4d).  Moreover, 
ectopically-expressed Gld4-Flag and CPEB-HA co-immunoprecipitate together (Fig. 4c). 
Importantly, Gld-4-flag immunoprecipitates p53 mRNA in knockdown control cells (shTETR) 
but not in CPEB knockdown cells (Fig. 4b). 
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DISCUSSION 
 
The polyadenylation of almost all mRNAs occurs after 3‟ poly(A) site selection and 
cleavage in the nucleus (Mathews et al. 2007). However, as exemplified by the Xenopus oocyte 
maturation, the poly(A) tail shortening and lengthening is a crucial strategy to regulate 
translation of specific mRNAs (Mendez and Richter 2001). One such mechanism that affords 
post-transcriptional regulation through poly(A) tail shortening and lengthening is meditated 
through a complex of proteins that, at its core, has the CPEB RNA-binding protein (Richter 
2007). Much is known about how CPEB and the associated factors deadenylate and 
polyadenylate specific mRNAs in the Xenopus oocyte (Richter 2007). However, little is known 
about how this feat is accomplished in higher vertebrate metazoans. Because our laboratory 
recently identified a biologically relevant and important target of the CPEB-polyadenylation 
complex during senescence onset (Burns and Richter 2008), we sought to further characterize the 
mechanism of how CPEB might add adenylates to mRNAs. Starting by knocking down the 
previously identified poly(A) polymerase xGld-2 (Barnard et al. 2004), we unexpectedly find a 
complex translational control cascade involving miR-122 control of CPEB mRNA translation 
and identify a compensatory or alternative non-canonical poly(A) polymerase hGld-4 (Schmid et 
al. 2009) required for p53 mRNA polyadenylation. 
 After the unexpected finding that hGld-2 knockdown increased p53 polyadenylation and 
translation, we wondered why hGld-2, which is co-expressed with CPEB mRNA, is not in 
complex with CPEB?  There are at least three possibilities. Firstly, Gld-2 could be unavailable, 
found in alternative complexes with other RNA-binding proteins or retained in the nucleus (data 
not shown) to function in alternative complexes. Consistent with this idea, is the finding that 
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CPEB4 can co-immunoprecipitate xGld-2 in Xenopus extracts(Igea and Mendez 2010). 
Secondly, perhaps xGld-2 is not as conserved in the way we might have predicted (Igea and 
Mendez 2010). Consistent with this possibility is that xGld-2 shares only ~40% amino acid 
identity with its human orthologue. Thirdly, perhaps Gld-2 is post-translationally modified in 
ways that exclude it from CPEB-complex in somatic cells versus early embryonic cells. The 
elucidation of Gld-2 function in human somatic cells awaits further experimentation. 
Why would miR-122 regulate CPEB mRNA translation? Translational control cascades 
are commonplace when rapid and coordinated cytoplasmic events occur as illustrated the process 
of meiotic resumption in the Xenopus oocyte (Vasudevan et al. 2006). Perhaps coordinated p53 
mRNA translation ensures a rapid response by increasing p53 protein levels sufficient to enact 
cell cycle arrest during cell division when ongoing transcription is absent. Also, post-
transcriptional regulation by various RNA-binding proteins could combinatorially organize and 
regulate p53 mRNA specifically to promote translation in opposition to other CPEB target 
mRNAs. Along these lines, the Filipowicz group has demonstrated that ectopic Hu antigen R 
(HuR), an AU-rich RNA binding protein, is able to antagonize miR-122 function causing the 
derepression of CAT-1 reporter mRNA (Bhattacharyya et al. 2006). Interestingly, HuR has been 
linked to p53 mRNA stability (Gorospe 2003; Mazan-Mamczarz et al. 2003). Perhaps the 3‟-
UTR is more intricately involved in the translation of p53 mRNA than has been fully realized. 
As the Suzuki laboratory first demonstrated, and we confirm here, Gld-2 is required for 
the stabilization of miR-122 and its normal expression (Katoh et al. 2009). We focus on miR-122 
as being Gld-2 regulated, but are struck by the lack of data on other microRNAs that are 
similarly regulated and wonder if the adenylation of small non-coding RNAs is more common 
and widespread than we think? Recent deep sequencing results of small RNAs demonstrate that 
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approximately 20% of all RNA-seq reads from cloned neuroblastoma miRNAs have a non-
templated adenylate in the first position, suggests it is more than probable (Schulte et al. 2009). 
While stabilizing microRNAs by non-template adenylate addition is a feasible strategy to 
regulate mRNA translation and/or mRNA stability, how and why Gld-2 polymerase activity is 
limited to add only one adylate to the 3-prime end of microRNAs is unknown. The mechanism 
of Gld-2 adenylate addition awaits further experimentation.  
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METHODS 
 
Cells and culture conditions 
Primary human foreskin fibroblasts were obtained from the Cell Culture Core Facility of 
the Yale University Skin Disease Research Center and cultured as described (Rangarajan et al. 
2004) in Dulbecco‟s Modified Eagle‟s Medium (DMEM) containing 10% fetal calf serum.  
About 106 cells, counted with a hemocytometer following treatment with trypan blue, were 
passaged every three days.  Human lung WI-38 fibroblasts were cultured in a similar manner. 
 
Virus production, infection, and cell lines 
 
Amphotropic retroviruses and lentiviruses were produced by transient transfection of 
293T cells with a transfer vector and amphotropic packaging plasmids encoding VSV-G and 
gag-pol using Lipofectamine 2000 (Invitrogen). Human cells at 50% confluency were infected 
for 8-12 hr with viral supernatants containing 7μg/ml polybrene. Typically 70-90% infection 
efficiency was achieved as assessed by using a GFP-encoding viral gene or by immunostaining 
cells using anti-HA (Covance). After infection, fresh media was added to the infected fibroblasts. 
 Some cells were analyzed by western blotting for, p53 (DO-1, Neomarkers), and b-actin 
(Abcam).  Other cells were fixed with 0.2% glutaraldehyde and stained for b-galactosidase 
activity at acidic pH according to Dimri et al (1995). 
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Oxygen Consumption 
 
To measure oxygen consumption, ~4x105 cells were washed and resuspended in 200 ml Krebs-
Ringers solution plus HEPES (125 mM NaCl, 1.4 mM KCl, 20 mM HEPES, pH 7.4, 5 mM 
NaHCO3, 1.2 mM MgSO4, 1.2 mM KH2,PO4, 1 mM CaCl2) containing 1% BSA.  Cells from 
each condition were aliquoted into a BD Oxygen Biosensor System plate (BD Biosciences) in 
triplicate.  Plates were assayed on a SAFIRE multimode microplate spectrophotometer (Tecan) 
at 1-minute intervals for 60 minutes at an excitation wavelength of 485 nm and emission 
wavelength of 630 nm.  
 
Analysis of p53 
 
Control and shCPEB infected fibroblasts were cultured in methionine and cysteine-free media 
(Invitrogen) for 45 min and then cultured in media containing 140 mCi 35S methionine and 35S 
cysteine (ProMix, Amersham) for 30 min.  The cells were then washed and cultured in fresh 
DMEM supplemented with 2 mM each of methionine and cysteine for the times indicated.  The 
cells were then frozen and stored until they were lysed and used to immunoprecipitate p53 (DO-
1 antibody, Neomarkers), which was analyze by SDS-PAGE and phosphorimaging. 
Additionally, Cells were cultured in methionine/cysteine free media as noted above in the 
presence of MG132, a proteasome inhibitor, for 30 min., followed by a 15 min culture in 100 
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µCi 35S methionine and cysteine; p53 was then immunoprecipitated and analyzed as noted 
above. 
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FIGURES 
 
Figure 1.  Depletion of Gld2 enhances p53 expression. 
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Figure 1.  Depletion of Gld2 enhances p53 expression.  (a) RT-PCR of Gld2 and tubulin RNAs 
following infection of human foreskin fibroblasts with a lentivirus containing an shRNA against 
Gld2 (b) Knockdown of Gld-2-HA in cells infected with a retrovirus expressing Gld2-HA and a 
lentivirus expressing shRNA for Gld2.  Tubulin served as a loading control. (c) Western blot 
showing enhanced expression of p53 following knockdown of Gld2. (d)  Ligation-mediated 
polyadenylation test (LM-PAT) assay was used to estimate the poly(A) tail length of p53 mRNA 
in WT cells, shGld-2 knockdown cells (two shRNAs targeting different regions of Gld2 were 
used), cells expressing ectopic CPEB, and cells expressing ectopic that lacks a zinc finger and 
hence is u nable to bind RNA (CPEB∆ZF)  (Burns and Richter, 2008). (e)  Oxygen consumption 
in cells infected with shCPEB, shGld-2, or empty vector. (f) Mock or shGld2 infected cells were 
stained for ß-galactosidase at acidic pH, which denotes cellular senescence.  Cell number was 
also determined with a haemocytometer, population doublings were plotted as growth curves of 
wild type cells or cells infected with shGld2. 
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Figure 2.  Gld2 knockdown increases CPEB mRNA and translation by a post-transcriptional 
mechanism. 
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Figure 2.  Gld2 knockdown increases CPEB mRNA and translation by a post-transcriptional 
mechanism. (a) Fold change of nuclear (intron-containing) or predominantly cytoplasmic (exon-
containing) CPEB following Gld2 depletion.  Actin RNA was used to normalize qRT-PCR data. 
(b) A schematic of Rluc-CPEB-3‟-UTR reporter constructs used in the following experiments. (c 
and d) Cells were infected with plasmids encoding firefly luciferase as a control and the Renilla 
luciferase plasmids noted in panel B.  The cells were then depleted of Gld2 and the amount of 
Renilla luciferase, relative to firefly luciferase, was determined.  The amount of Renilla lucifease 
activity derived from RNA containing the entire CPEB 3‟UTR was arbitrarily set at 100.  
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Figure 3.  miR-122 activates p53 mRNA translation by repressing CPEB mRNA expression. 
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Figure 3.  miR-122 activates p53 mRNA translation by repressing CPEB mRNA expression. (a) 
Human skin fibroblasts were transduced with firefly luciferase as an internal standard and 
Renilla luciferase appended with the full length CPEB 3‟ UTR or UTRs containing deletions in 
putative miR-122 binding sites.  The data are expressed as described in Figure 2. (b) Skin 
fibroblasts were transduced with plasmids encoding firefly and Renilla luciferase containing the 
full length CPEB 3‟ UTR and then electroporated with miR-122 LNA antagomir, an LNA with a 
scrambled sequence, or no LNA.  The luciferase data are expressed as described in Figure 2. (c) 
mir-122 expression levels were measured using qPCR for the mature mir-122 and normalized to 
actin mRNA expression levels. (d and e) Skin fibroblasts transduced with Mock-GFP, miR-122 
LNA, or scrambled LNA were incubated in methoinine and cysteine-free medium containing the 
proteosome inhibitor MG132 for 30 minutes, followed by a pulse incubation with 35S-methionine 
for 15 min. p53 protein was then immunoprecipitated from these cells and resolved by SDS-
PAGE, as was total cell protein. Gels were exposed to phosphor-imaging screens and quantified 
using ImageQuant software. (f) Skin fibroblasts were treated as in panels c and d after first being 
infected with lentiviruses expressing either shRNAs against the TET repressor as a control or 
CPEB. 
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Figure 4.  Gld-4 is an alternative poly(a) polymerase required for normal p53 polyadenylation. 
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Figure 4.  Gld-4 is an alternative poly(a) polymerase required for normal p53 polyadenylation. 
(a) Western blot of p53 from normal hFS cells that express either shGld-4 or shMitoPAP. (b) p53 
mRNA is immunoprecipitated by Gld-4-flag from cells which have been infected with a 
lentivirus expressing either knockdown control (shTETR) or CPEB knockdown. GAPDH is used 
as a negative control as it lacks CPEs. (c) Co-immunoprecipitations from (hFS or Hela) cells 
transfected with Gld-4-Flag and CPEB-HA constructs. (d) LM-PAT from either Mock or shGld-
4 infected cells. The poly(a) tail length is quantitated for Mock and shGld-4 treated cells. (e) 
semi-quantitative RT-PCR amplification of p53-exon specific or p53-intron specific in Mock, 
shGld-4 or shMitoPap cells. 
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Figure 5. Proposed model of Gld-2 stabilization of mir-122, CPEB mRNA repression, and 
reduced p53 polyadenylation 
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Figure 5. Our findings suggest a model where Gld-2 adenylates miR-122 thereby stabilizing 
miR-122 and repressing the translation of CPEB mRNA. If miR-122‟s stability is affected by the 
loss of Gld-2, CPEB mRNA is derepressed and translated where it can then bind p53 mRNA to 
polyadenylate p53 mRNA by Gld-4. 
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Supplemental Figure 1. MiR-122 binding sites on the 3‟ UTR of CPEB mRNA 
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CHAPTER 4 
 
GENERAL DISCUSSION, CONCLUSION AND PREDICTIONS 
 
 
In the previous chapters, I have presented evidence for the requirement of CPEB and 
cytoplasmic polyadenylation for the onset of senescence and p53 mRNA polyadenylation. The 
finding that CPEB is required for the normal polyadenylation of p53 mRNA is significant for 
two major reasons; i) p53 is a tumor suppressor protein commonly mutated in ~50% of all 
human cancers, and ii) p53 is a crucial regulator of the response to DNA damage and other 
genotoxic stresses such as reactive oxygen species (ROS). I have also demonstrated that CPEB, 
surprisingly, does not require the non-canonical Gld-2 polyadenylation enzyme, but instead 
requires Gld-4 for p53 mRNA polyadenylation and translation. Interestingly, Gld-2 regulates the 
stability of microRNA-122 that in turn regulates the translation and stability of CPEB mRNA.  
The findings presented here exemplify two major themes in the field of translation 
control. First, translational control mechanisms are often conserved in cells and tissues as distant 
as oocytes, neurons, and now somatic skin fibroblasts (Mathews et al. 2007; Richter 2007). 
Second, translational control cascades can rapidly regulate important cellular processes like 
hormone-induced meiotic cell cycle resumption and cell cycle arrest and senescence (Vasudevan 
et al. 2006). However, my work also demonstrates that the CPEB-complex composition and 
enzymatic partner proteins are perhaps different and less conserved in function then previously 
appreciated. Regardless, these experiments offer novel lines of questioning and further 
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experimentation. Also, several interesting predictions about CPEB function in other cellular 
contexts can be made from my work. 
 
CPEB knockout mouse 
 
 Several lines of evidence had previously suggested the potential importance of 
investigating CPEB function in higher vertebrates. Namely, CPEB was found to regulate 
essential mRNAs in the early meiotic cell cycle, e.g. cyclin B and mos mRNAs. Furthermore, 
CPEB had also been shown to play a critical role the mitotic cell cycle (Stebbins-Boaz et al. 
1996; Mendez et al. 2000a; Groisman et al. 2001; Groisman et al. 2002). While both female and 
male CPEB KO mice are sterile – CPEB KO females lack ovaries and CPEB KO males are 
afflicted with hypogonadism due to defects in germ cell development – CPEB KO mice appear 
otherwise normal (Tay and Richter 2001). Due to the predicted role of CPEB-complex function 
in the mitotic cell cycle, murine embryonic fibroblasts (MEFs) were cultured from these CPEB 
KO embryos (Groisman et al. 2006). Unlike WT MEFs which enter a cell cycle arrest termed 
cellular senescence, CPEB KO MEFs continue to proliferate, bypass senescence, and are 
immortal (Groisman et al. 2006). However, because CPEB is required for mitotic cell division 
one might have predicted that these experiments would have never been possible due to 
insufficient Cdk1 activity, principally due to defects in cyclin B mRNA translation. Interestingly, 
recent experiments from the Mendez Group show that CPEB4 may compensate for CPEB1 in 
function (Igea and Mendez 2010). Thus, other CPEB family members may compensate for the 
loss of CPEB1, as exemplified by the work concerning the D-type cyclins, where other family 
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member proteins can compensate for Cyclin D1 function when Cyclin D1 is knocked out in the 
mouse (Ciemerych et al. 2002; Kozar et al. 2004). However, the possibility of CPEB4 
compensating in function for CPEB1 seems unlikely for two reasons: i) CPEB1 and CPEB4 bind 
different consensus sequences (Huang et al. 2006), and ii) CPEB4 seemingly requires CPEB1 for 
its translation (Igea and Mendez 2010) even though CPEB4 protein is detectable in mice 
(unpublished data). Regardless, further experimentation is required to determine whether CPEB4 
compensates for the loss of CPEB1. Further breeding experiments between CPEB1 and other 
CPEB family members would either exclude the issue of compensation or, more interestingly, 
show some degree of compensation. Sterility of the CPEB1 KO mice present technical issues 
and the lack of a CPEB4 KO mouse make these experiments unfeasible. However, because 
CPEB4 also has been shown to bind the polyadenylation enzyme xGld-2 in Xenopus extracts 
(Igea and Mendez 2010), perhaps CPEB4 similarly interacts with Gld-2 or Gld-4. Perhaps a 
more feasible strategy would be to study the enzymes responsible for poly(A) addition, not 
merely the mRNA-binding specificity factors which merely nucleate these complexes. 
Even though the CPEB KO mouse presents few abnormal phenotypes, ongoing studies in 
our laboratory suggest that some stress or state change may be required to reveal additional 
aberrant phenotypes. For example, cell culture stress was needed to reveal the bypass in 
senescence of CPEB KO MEFs. Thus, looking in the correct tissue(s) under the right stress-
conditions may reveal additional defects or aberrant phenotypes. I will therefore speculate in the 
following sections, of other potential tissue(s) and biologically relevant contexts for further 
investigation.  
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Role of CPEB in senescence 
 
 Senescence, like apoptosis, limits the growth of aberrantly proliferating cells; cells that 
bypass senescence may go on to form malignant tumors (Collado et al. 2005; Collado and 
Serrano 2005; Collado et al. 2007). CPEB is required for the normal onset of senescence and 
normal polyadenylation of the tumor suppressor protein p53 (Burns and Richter 2008); it is 
possible CPEs are highly mutated in cancer cells, thus disrupting normal p53 function. While, 
mutation of the putative CPE motifs found in p53 mRNA has not been formally tested, in an 
alternative observation from tumor cells,  the shortening of 3‟-UTRs prior to transformation does 
occur (Mayr and Bartel, 2009). The mechanism for 3‟-UTR shortening is alternative 
polyadenylation site selection (APA) by an as yet an unknown mechanism. Several mechanisms 
are proposed, such as increases in the concentration of poly(A) cleavage and specificity factors 
(Ji and Tian 2009), nucleosome positioning (Spies et al. 2009), and DNA methylation (Wood et 
al. 2008). The 3‟-UTR is essential for contributing RNA sequences required for association of 
trans-acting factors, like cognate miRISCs and RNA-binding proteins. It is plausible that both 
CPEB and p53 mRNAs may experience 3‟-UTR shortening. While CPEB and p53 do not have 
any obvious alternative poly(A) sites, expressed sequence tags (ESTs) from the UCSC genome 
browser predict that in different stages of development both may have a shortened 3‟-UTRs. P53 
mRNA 3‟-UTR shortening would affect CPEB binding as well. No one has investigated 3‟-UTR 
shortening of p53 and its associated consequences during tumorgenesis.  
Beyond its primary role of tumor suppression, senescence also limits the efficiency of 
nuclear reprogramming in induced pluripotent stem (iPS) cells. Reprogramming Induced 
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Senescence (RIS) limits the efficiency of nuclear reprogramming by the four so-called 
Yamanaka factors – Oct4/Sox2/Klf4/c-Myc (Banito et al. 2009; Banito and Gil 2010). The 
discovery of iPS cellular reprogramming was a major scientific breakthrough for two major 
reasons: i) iPS cell induction will allow the study of cells from patients with various diseases in 
unprecedented ways (Nishikawa et al. 2008) and ii) it will allow the generation of stem cells that 
are isogenic to the patients, thus allowing them to be re-injected back into the same patient with 
less probability of host or xenographic rejection. Somatic cell reprogramming is a major 
scientific breakthrough for not only the study of developmentally related diseases, but potentially 
for regenerative and translational medicine (Yamanaka and Blau 2010). 
  One of the major limitations of nuclear reprogramming iPS cells is senescence; since 
CPEB KO MEFs and Kd foreskin cells clearly have defects in senescence onset, one interesting 
prediction is that both CPEB KO MEFs and Kd human foreskin cells should reprogram with 
much higher efficiency. Two lines of questions and experimentation could then follow: is RIS 
and cellular senescence regulation by CPEB similar, and is CPEB required for differentiation 
into a particular cell type, e.g. ovaries, testes, gametes or neurons? Additionally, iPS cellular 
reprogramming might allow for the study of CPEB function in human neurons. 
 
Non-canonical 3’ additions to microRNAs 
 
 Small non-coding RNAs called microRNAs regulate both the translation and stability of 
mRNA(Richter 2008). It is becoming more apparent that microRNAs are themselves regulated at 
both the level of processing by Dicer and Lin28 and stability by non-templated adenylate 
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addition (Kai and Pasquinelli 2010). microRNAs are primarily destabilized by the addition of 
multiple uridylates by Lin28 and Tut-4 (Heo et al. 2008; Hagan et al. 2009; Heo et al. 2009). 
Equally interesting is the stabilization of microRNAs by the addition of one non-DNA-templated 
adenylate. Surprisingly, Gld-2 poly(A) polymerase is shown by the Suzuki group via loss-of 
function studies to stabilize miR-122 (Katoh et al. 2009). Gld-2, first identified by Dr. Judith 
Kimble to be the poly(A) polymerase important for early germ line differentiation (Wang et al. 
2002; Wang et al. 2004), was later demonstrated by the Richter group to polyadenylate mRNAs 
during oocyte maturation (Barnard et al. 2004). Furthermore, in an attempt to demonstrate the 
requirement for Gld-2 and p53 mRNA polyadenylation, I unexpectedly find that Gld-2 is not 
required for p53 mRNA polyadenylation. Instead, I confirm the findings from Suzuki group 
(Katoh et al. 2009), that Gld-2 regulates the stability of miR-122, as well as establish that the 
stability of miR-122 is important for the translational repression of both CPEB directly and p53 
indirectly by CPEB and Gld-4. 
 As my work demonstrates the biological importance of microRNA stabilization, it is 
therefore worth considering how widespread the stabilization of microRNAs by adenylate 
addition is, and what roles this may play in other biological contexts. Recent deep sequencing 
experiments suggest that non-templated adenylate addition is quite prevalent (Schulte et al. 
2009). By bioinformantic analysis of RNA-seq data, Schulte et al. (2009) find that 20% of all 
micoRNA reads have a non-templated adenylate (Schulte et al. 2009).  Additionally, it is also 
likely Gld-2 is the principal non-canonical poly(A) polymerase responsible for the adenylate 
addition (Katoh et al. 2009); this deserves further experimentation, i.e. small RNA cloning and 
next generation RNA-sequencing. The Gld-2 knockout mouse does exist and is viable indicating 
that Gld-2 mediated adenylate addition is not essential for embryonic development (Nakanishi et 
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al. 2007). Regardless, the question of how Gld-2 mechanistically adds only one adenylate and 
how this one adenylate stabilizes microRNAs is central to the study of miRNA-mediated 
regulation and should be investigated further. Because polyadenylate stretches both stabilize 
mRNAs and increase their translational efficiency by additional factors, namely PABPs, 
additional factors are most likely required for microRNA stabilization and await identification.  
 
Predictions: CPEB in other cellular contexts 
 
 In the previous chapter, I demonstrated a mechanistic link between CPEB mRNA 
translation and microRNA-122 (miR-122). I will therefore consider possible roles for CPEB in 
relation to previously characterized miR-122 functions. One of the most provocative connections 
of mir-122 to CPEB is the requirement of miR-122 for Hepatitis C Virus (HCV) replication. 
Interestingly, HCV not only requires miR-122 for viral replication (Jopling et al. 2005; Sarnow 
et al. 2006) but also the DEAD-box helicase DDX6 for viral gene expression (Jangra et al.; 
Smillie and Sommerville 2002; Weston and Sommerville 2006; Jopling et al. 2008). Previous 
studies by the Standart group demonstrate CPEB co-immunoprecipitates with DDX6, also 
known as p54/RCK (Minshall et al. 2001; Minshall et al. 2009). Because DDX6 is required for 
HCV gene expression, one would predict that by ectopically overexpressing CPEB, DDX6 
would potentially be titrated out and HCV gene expression inhibited. However, one must 
consider that upon ectopic expression of CPEB, most likely, p53 mRNA would increase in 
translation. Interestingly, miR-122 can regulate CPEB mRNA translation. MiR-122 is required 
for HCV stabilization and replication (Jopling et al. 2005). Thus, does CPEB increase in 
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expression after HCV infection due to the inhibition of normally expressed miR-122 by HCV? If 
this were the case, then one would predict a commensurate increase in CPEB/DDX6 interaction. 
Presumably, this increase interaction would benefit HCV by either increasing HCV gene 
expression or potentially decreasing p53 translation. The possibility of CPEB decreasing p53 
translation is likely as DDX6 inhibits translation by interaction with the 7mG capped mRNA 
(Weston and Sommerville 2006). 
 MiR-122 has also been described as a gene under circadian control in liver cells, where 
the primary transcript for miR-122 oscillates after light-induced entrainment (Gatfield et al. 
2009). Interestingly, no change in the overall levels of mature miR-122 was observed (Gatfield et 
al. 2009). Gatfield et al. (2009), as demonstrated by microarray experiments that newly 
transcribed  mRNAs instead increase and therefore putatively regulated miR-122 mRNAs are 
under differential ratios of miR-122 to total mRNAs (Gatfield et al. 2009). Gatfield et al. (2009) 
surmise that due to dilution effects of cognate miRISC loaded with miR-122 relative to miR-122 
targeted genes, the miR-122 targeted genes are de-repressed translationally. They further 
substantiate this hypothesis by demonstrating that miR-122 targeted reporter constructs are 
translationally derepressed (Gatfield et al. 2009). Perhaps CPEB is also differentially regulated in 
liver cells and plays a translational regulatory role in the circadian regulation of gene expression. 
MiR-122 is also antagonized in function by the embryonic-like-abnormal-vision-like 
(ELAVL) protein Hu Antigen R (HuR) (Bhattacharyya et al. 2006). Studies from the Filipowicz 
group show the translational repression of CAT-1 mRNA by miR-122 is reversible. Inhibition of 
miR-122 via ectopic expression of HuR abrogates the translational repression of CAT-1 mRNA 
reporter  (Bhattacharyya et al. 2006). Interestingly, HuR plays a significant role in mRNA 
stabilization during genotoxic stress, where it has been shown to translocate from the nucleus to 
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the cytosol to stabilize mRNAs and indirectly promote the translation of mRNAs (Gorospe 
2003). Also, HuR has been shown to directly bind  radiolabeled p53 RNA in UV-irradiation 
experiments which increases the stability and the translation of p53 mRNA(Mazan-Mamczarz et 
al. 2003). Because p53 does not contain any putative miR-122 binding sites, does HuR 
concomitantly antagonize miR-122 function on CPEB mRNA by de-repressing CPEB mRNA 
translation to promote p53 polyadenylation, stabilization, and translation? UV-irradiation 
experiments in HuR and CPEB knockdown versus WT cells could empirically test this question. 
 
Conclusion of the Discussion 
 
 CPEB is an important trans-acting factor that can regulate transport and translation of 
mRNAs (Richter 2007). While CPEB has been rigorously studied in Xenopus oocytes in the 
context of oocyte maturation, CPEB function is conserved in other vertebrate metazoan somatic 
cells, such as neurons and skin cells. Because we know much of CPEB function and little of the 
specific mRNAs it might regulate, further non-biased approaches that utilize next-generation 
sequencing (RNA-seq) and new laboratory techniques like UV-cross-link-IP (CLIP) have the 
potential to reveal additional CPEB target mRNAs. However, regardless of how many new 
targets are identified by such methods, understanding the function of CPEB-associated complex 
members is critical for understanding the role of CPEB bound mRNAs within a given cellular 
context. The work presented here demonstrates a novel CPEB complex member and regulatory 
features of CPEB mRNA translation within the biologically relevant context of cellular 
senescence may provide additional biological contexts for further studies of CPEB function. 
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